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ABSTRACT
REGULATION OF CD8+ T CELL RESPONSES TO TOXOPLASMA GONDII
Kimberly A. Jordan
Christopher A. Hunter
Protective immunity to Toxoplasma gondii, an intracellular protozoan parasite, is
characterized by a strongly polarized Th1-mediated immune response that is dependent
on CD4+ and CD8+ T cells. In order to study the factors that influence development of
CD8+ T cell responses to this parasite, a system was developed using a replicationdeficient parasite that expressed the model antigen ovalbumin (OVA). These initial
studies revealed that an OVA-specific CD8+ T cell response was induced and peaked at
day 10 post-immunization, that the primary response was CD4+ T cell-dependent, and
that the cells induced by immunization primarily resembled effector cells. Protective
immunity to rechallenge using this model was mediated by CD8+ T cells. Long-term
study of the CD8+ T cell response was undertaken, in WT mice as well as in c-Rel-/- mice,
which are susceptible to T. gondii infection. In these studies, c-Rel was required for
optimal primary expansion of CD8+ T cells in response to T. gondii. Surprisingly, while
T cells express c-Rel, it was not intrinsically required by the T cells themselves, since
adoptive transfer of c-Rel-/- CD8+ T cells to WT mice restored their expansion. Further
examination revealed that the inflammatory environment but not the T cells themselves
required expression of c-Rel, because exogenous IL-12 rescues the CD8+ T cell responses
in c-Rel-/- mice. Maintenance of memory CD8+ T cells as well as secondary expansion of
these cells following challenge was independent of c-Rel. This work provided the first
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characterization of an antigen-specific memory CD8+ T cell response to non-replicating
strain of T. gondii as well as showing that c-Rel is not intrinsically required by CD8+ T
cells for expansion or effector function following infection, and provides new insights
into the requirements for memory cell formation.
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Chapter 1 : Literature Review
Introduction
Since Toxoplasma gondii was initially described as a pathogen of rodents in 1908,
there has been steady progress in understanding the different developmental stages
involved in its complex life cycle. Particularly important was the recognition that this
parasite can infect any warm-blooded vertebrate. Though congenital infection was the
first method of transmission to be understood, additional methods of transmission of T.
gondii were clarified when it became evident that infective forms of the parasite could be
found in the tissues of animals as well as in the environment. Initial descriptions of the
ability of T. gondii to cause congenital disease highlighted its public health importance
and this was reinforced by the recognition that T. gondii was an important opportunistic
pathogen in immunocompromised patients. In particular, the susceptibility of patients
with primary or acquired immune defects in T cell function highlighted the importance of
these lymphocytes in preventing reactivation of persistent latent infection. This in turn
led to intense study using animal models that defined the events that result in protective
immunity, including the important role played by CD8+ T cells and the cytokine IFN-" in
the long-term resistance to T. gondii. The studies presented here begin to clarify some
unanswered questions about the development of a CD8+ T cell response, and the
maintenance of a memory population, that are critical for protection against T. gondii.
This section of my thesis will discuss the biology of the parasite, the host innate immune
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response it provokes, and the main factors that lead to the development of a protective
immune response.

1.1 Toxoplasma gondii
Toxoplasma gondii is an intracellular protozoan parasite of the phylum
Apicomplexa, a group that includes Plasmodium, Sarcocystis, and Cryptosporidium, and
infection with these parasites results in considerable human and animal morbidity and
mortality worldwide. T. gondii was first identified in a North African rodent called the
gundis over 100 years ago, by researchers in Tunis (Nicolle and Manceaux, 1908), and
coincidently described in the rabbit by others in Brazil (Splendore, 1908). It was not until
1939 that T. gondii parasites were first recognized in humans, specifically in the brain of
a congenitally infected infant with encephalomyelitis (Wolf et al., 1939). Parasites
isolated from this patient’s tissue could be transferred back into mice, rabbits or rats
where they replicated and caused disease. Since that time there has been a growing
appreciation of the public health importance of T. gondii, as well as its usefulness as a
model organism to study various aspects of the biology of other Apicomplexa including
Plasmodium. In this thesis I will explore the regulation of the CD8+ T cell response
against T. gondii, discuss the importance of this immune cell subset in the initial response
to infection, and describe the implications of these studies for memory formation and
vaccine development.

2
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1.1.1 Life cycle
The ability of T. gondii to survive in many different species throughout a variety
of climates is a consequence of many different factors in its life cycle (Figure 1). It has
several developmental stages (oocysts, tissue cysts) that facilitate transmission from host
to host, or persistence in the environment in a latent form. It can also be transmitted
during an acute infection from mother to fetus due to the ability of the tachyzoite form to
cross the placenta (Cowen and Wolf, 1950). However, a relatively recent large-scale
study of Toxoplasma infection in Europe has suggested that the major risk factor for
infection is consumption of undercooked or improperly cured meat (Cook et al., 2000).
T. gondii can undergo either asexual or sexual reproduction, though sexual
reproduction only occurs in its definitive felid host (Figure 1) and thus will not be
discussed in depth any further for the purposes of this thesis. Unlike other protozoa, for
example the malaria parasite, the sexual phase of the T. gondii life cycle is not required,
and serves to enhance the diversity of the species. As noted above, there are two
infectious forms of T. gondii. Oocysts are the product of sexual recombination in the cat
and contaminate the environment, while bradyzoites are found within tissue cysts of
chronically infected animals. Following ingestion of either of these infective cysts, T.
gondii undergoes rapid transformation into tachyzoites. This stage of the parasite can
enter nearly any nucleated cell of the host in an active invasion process that is driven by
an actin/myosin-based motor complex (Carruthers and Boothroyd, 2007). Following
attachment to the outside of a target cell, T. gondii tachyzoites then inject the contents of
4

specialized secretory organelles called the rhoptries (Dubremetz, 2007), allowing
formation of a protective double-membraned compartment called the parasitophorous
vacuole (PV). This PV is made up of parasite components but also host cell membrane
(Melo and de Souza, 1997; Suss-Toby et al., 1996). Within this vacuole the parasite
replicates rapidly via the process of endodyogeny, the internal budding process by which
parent cells produce two daughter cells (Goldman et al., 1958). This process eventually
leads to host cell lysis (Dzierszinski et al., 2004).
It is not yet clear how parasite dissemination from initial points of infection to
distal sites occurs, and though extracellular tachyzoites have been found in the
bloodstream (Unno et al., 2008), there are also data to support the concept that
dissemination occurs via infected cells. For example, phagocytes harboring single
parasites were found in the blood of experimentally infected mice, and could rapidly
traffic to the brain (Courret et al., 2006). Additionally, adoptive transfer of tachyzoiteinfected DC enhanced parasite dissemination, when compared to mice infected with free
parasites, in a process that was dependent on G-protein coupled receptor signaling
(Lambert et al., 2006). Thus, the acute infection stage of T. gondii is characterized by
parasite replication and dissemination, and the accompanying development of antiparasite host immunity. This in turn leads to stress on the parasites and the formation of
latent bradyzoite-containing cysts that characterize the chronic stage of infection and
allow the parasite to persist.
The transition from tachyzoite to bradyzoite in vitro has been linked with a
number of environmental stressors including temperature and pH (Soete et al., 1994;
5

Weiss et al., 1994), but in vivo, immune stresses such as nitric oxide (NO) are probably
the relevant stimuli. Accompanying developmental stages of the parasite is a specific
gene expression profile related to its metabolism and morphology (Dzierszinski et al.,
2001; Dzierszinski et al., 2004; Kibe et al., 2005). There are several potential
explanations for this change in gene expression, including evasion of the host immune
response by the parasite, as studies found that expression of surface antigens differs
between tachyzoites and bradyzoites (Kim and Boothroyd, 2005; Kim et al., 2007).
Adaptation by T. gondii to its new environment is another potential explanation, since the
parasite’s metabolism differs drastically between the lytic versus latent phase.
Regardless, this differentiation within the host to the latent bradyzoite stage is required
for long-term persistence and current paradigms suggest that the majority of healthy
chronically infected individuals, animal or human, exhibit no clinical indication of
disease.

1.1.2 T. gondii population structure

As a result of its ability to undergo sexual recombination in the cat, there is the
potential for T. gondii to generate high levels of genetic variation. However, analysis of
the population structure of T. gondii has revealed that this organism can be grouped into
three clonal lineages, with each of these lineages demonstrating variations in gene
expression, epidemiology and virulence (Howe et al., 1997). Conflicting reports exist as
to which strains most commonly cause disease in humans, but based on well-accepted
animal models it is generally agreed that Type I (typified by the RH strain) are virulent,
while Type II (typified by the Prugniaud strain, “Pru”) and Type III strains are
6

considerably less so (Boothroyd and Grigg, 2002; Fuentes et al., 2001; Howe et al., 1997;
Khan et al., 2005). Genetic approaches developed in the last 20 years have lead to
mapping of virulence factors and shown that virulence can be attributed, in part, to the
secreted proteins ROP16 and ROP18, which get secreted into the host cell cytoplasm
following invasion (Saeij et al., 2006; Taylor et al., 2006). The majority of the work for
this thesis was undertaken using a modified Type I strain that had lost the ability to
replicate in vivo, and could not form cysts. In addition, studies were undertaken by this
laboratory to compare the generation of CD8+ T cell responses against Type I vs. Type II
strains and these studies will be further discussed in Chapter 3 and the discussion section.

1.2 Public health importance and vaccine prospects
T. gondii, together with Salmonella and Listeria, causes the majority of deaths
due to food-borne illnesses in the United States and is thus a major public health concern
(Mead et al., 1999). Antibody prevalence studies have suggested that anywhere from 1020% of the U.S. population is chronically infected with T. gondii (Jones et al., 2003),
though normally this infection is asymptomatic in healthy individuals. Significant clinical
disease can occur in individuals that are immunocompromised as a consequence of
acquired immunodeficiency caused by HIV, cancers such as Hodgkin’s lymphoma, or
because of specific treatments designed to suppress the immune system (Ferreira and
Borges, 2002). For example, while most humans are capable of mounting appropriate T
cell responses required to control T. gondii, the decline in CD4+ T cell numbers and loss
of CD8+ T cell function seen during AIDS can result in reactivation of latent T. gondii
and the development of life-threatening Toxoplasmic encephalitis (Luft et al., 1984). In
7

North America, while Type II strains of T. gondii are most prevalent in humans, disease
is more commonly associated with Type I strains (Grigg et al., 2001; Howe et al., 1997).
While alterations in immune status can profoundly alter the outcome of infection,
differences in the parasite population structure can also have a significant impact on the
ability of these organisms to cause disease. This is illustrated by recent reports that have
noted atypical strains of T. gondii associated with ocular disease or acute lethality in
immunocompetent individuals (Demar et al., 2007; Grigg et al., 2001; Khan et al.,
2006a).
Current drug regimens of sulfadiazine and pyrimethamine, though highly
effective against rapidly replicating tachyzoites, are unable to target the bradyzoite stage
of T. gondii due in part to decreased metabolic inactivity (Luft et al., 1984). Further,
while treatment of acutely infected pregnant women can limit the damage caused by
replicating parasites, it does not uniformly prevent transmission to the fetus (Thiebaut et
al., 2007). Meta-analysis of prenatal treatment against congenital toxoplasmosis has
shown that approximately 30% of babies born to infected mothers acquire T. gondii, and
up to 4% of these babies will die or exhibit permanent neurological defects or visual
impairment (Thiebaut et al., 2007). Because of the dangers associated with congenital
toxoplasmosis, and because cure of chronically infected individuals is impossible, the
development of a vaccine against this parasite is desirable. While a vaccine to prevent T.
gondii-induced abortions in cattle is commercially available (Buxton and Innes, 1995), it
uses a live attenuated strain of T. gondii and is therefore unlikely to be approved for use
in humans. It has also been proposed that a therapeutic approach would also be useful in
the instance of other chronic parasitic diseases, for instance in ameliorating the outcome
8

of Chagas disease caused by chronic Trypanosoma cruzi. Thus, even if the design of a
preventative vaccine were not successful, design of a therapeutic vaccine that targets
CD8+ T cell responses, or improvements to standard drug treatment, would be helpful to
limit the morbidity and mortality associated with clinical toxoplasmosis.

1.3 Model antigens and epitope discovery
Identification of the proteins that drive an immune response to T. gondii will not
only help to further understanding of immunity to infection, but also provide assistance
for rational vaccine design. Protozoan parasites have relatively large microbial genomes
compared to most viruses, for example the human immunodeficiency virus (HIV), which
contains only 9 genes. Therefore, design of predictive algorithms to identify endogenous
epitopes has been met with limited success. Antigen recognition during parasite infection
is further complicated by the distinct developmental stages associated with initiation of
infection, development of disease, and latency. For instance, T. gondii has been shown to
express different antigens, depending on the stage of infection, with some antigens being
expressed during the fast-replicating tachyzoite stage, and others expressed only when the
parasite has encysted in the brain and muscle tissue in its bradyzoite form (Frickel et al.,
2008; Kim and Boothroyd, 2005; Kwok et al., 2003; Lutjen et al., 2006).
At the time this thesis work was initiated, no endogenous CD8+ T cell epitopes
had yet been identified, so different groups including our laboratory used parasites that
expressed the model antigens ovalbumin or beta-galactosidase (Kwok et al., 2003; Lutjen
et al., 2006; Pepper et al., 2004). This is a strategy that has been used by many groups to
understand immunity to infection. For example, reports using L. major and T. cruzi that
9

expressed model antigens suggested preferential processing and presentation of secreted
antigens or proteins located on the cell surface (Bertholet et al., 2005; Garg et al., 1997).
Similar findings were seen with Salmonella, where secreted but not cytosolic antigens
were able to induce a potent immune response (Guzman et al., 1998).
Extensive efforts by many different groups have lead to the sequencing and
annotation of the T. gondii genome (El-Sayed et al., 2005; Gardner et al., 2002; Kissinger
et al., 2003), which facilitated the discovery of endogenous CD8+ T cell epitopes. Two
epitopes derived from dense granule and rhoptry proteins have been described in BALB/c
mice (Frickel et al., 2008), while another endogenous epitope found in B10.D2 mice was
derived from a dense granule protein (Blanchard et al., 2008). In T. cruzi, a major CD8+
T cell epitope making up to 20% of the total CD8+ T cell pool during acute infection was
identified in the trans-sialidase family, a surface and secreted protein (Martin et al.,
2006). Thus, in agreement with earlier work using model antigens, the majority of work
indicates that parasite-secreted proteins exit the parasitophorous vacuole and enter the
endogenous MHC Class I presentation pathway, thus becoming major targets in the
immune response to T. gondii.

1.4 Overview of Immunity to T. gondii
The study of the biology of T. gondii, as well as the host immune response it
induces, has yielded insight into not only this parasitic organism but also its importance
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as a model organism for other intracellular organisms. The ease by which T. gondii can
be propagated in vitro, as well as ability to genetically manipulate this parasite, have
contributed to further knowledge of antigen presentation and immunity induced by the
host. The study of infected human patients as well as numerous mouse studies have
shown that this organism elicits a strong Th1-type response, characterized by the ability
of accessory cell-derived IL-12 to promote generation of parasite-specific CD4+ and
CD8+ T cells that produce IFN-! (Figure 2).

1.4.1 Innate Immunity to T. gondii
Following oral infection, the first cells encountered by T. gondii are intestinal
epithelial cells. In response to infection with T. gondii tachyzoites, these cells have been
shown to produce cytotoxic molecules like NO as well as chemokines such as MCP-1,
MIP-1# and MIP-1$ (Mennechet et al., 2002). However, this organism does not remain
confined to the intestinal epithelium for very long. As early as 8 hours after oral infection
of mice T. gondii tachyzoites can be found in the mesenteric lymph nodes (Dubey et al.,
1997). It is not well known which cell types are acutely infected by T. gondii in the
intestine or the lymph node, though it has been suggested that antigen-presenting cells are
key targets, and this is an active area of investigation. More is known about the effects T.
gondii can have on infected cells. Early studies of innate immune responses to T. gondii
focused on the ability of macrophages to kill intracellular parasites, but our understanding
of the pathways that regulate innate recognition to intracellular parasites has expanded
immensely in the past two decades. Some of the molecular mechanisms behind these
12

early events will now be discussed, as will more recent genetic and biochemical
approaches to determine how T. gondii can directly interfere with these pathways.
Live parasites or proteins isolated from T. gondii have previously been used to
stimulate individual cell populations such as fibroblasts and macrophages to induce
cytokine or chemokine production (Brenier-Pinchart et al., 2000; Butcher and Denkers,
2002). This implies the presence of an innate recognition process that can occur in the
absence of adaptive immunity. A main pathway of innate antigen recognition is via the
Toll-like receptors (TLRs), an evolutionarily conserved group of receptors that
recognizes distinct groups of microbial antigens (or damage-induced host molecules). In
fact, several TLRs have been linked with the immune response to T. gondii (Gazzinelli
and Denkers, 2006) as well as a number of other pathogens (Kawai and Akira, 2007).
Most TLRs require the adapter protein MyD88 to transduce their signal, and initial
studies in mice lacking this gene revealed that MyD88 was required to prime Th1
responses against vaccination with T. gondii antigens (Jankovic et al., 2002). Moreover,
in vivo studies demonstrated that MyD88 was required to control acute infection with T.
gondii, similar to what was seen in IL-12p40 KO mice (Scanga et al., 2002), and that the
MyD88-KO mice challenged with T. gondii had reduced serum levels of IL-12p40
compared to WT mice. Later studies to clarify which TLRs were involved in this
response revealed that TLR11 is activated by a profilin-like protein (Yarovinsky et al.,
2005). TLR2 was required for survival against high-dose intraperitoneal challenge (Mun
et al., 2003) and TLR4 and TLR9 have also been implicated in responsiveness to T.
gondii-derived antigens in the gut following oral infection (Fang et al., 2008; Minns et
al., 2006).
13

Downstream of TLR activation, two important signaling cascades are induced:
NF-!B and Mitogen-Activated Protein Kinase (MAPK), both of which are highly
conserved pathways involved in the immune response. The role of NF-!B in immunity
will be discussed in more detail in Chapter 1.2. Perhaps not surprising given the complex
nature of T. gondii, other innate signaling pathways also contribute to recognition of this
organism. For instance, the T. gondii-derived protein cyclophilin-18 has been reported to
activate dendritic cells via interactions with CCR5 (Aliberti et al., 2003), and some
studies have demonstrated that CCR5-deficient mice had decreased survival and
increased parasite burdens following T. gondii infection (Khan et al., 2006b).
Consistent with the idea that these innate recognition events would promote the
eventual immune-mediated killing of T. gondii, the parasite has evolved multiple
mechanisms to interfere with these signaling pathways. For instance, several groups have
found that T. gondii interferes with NF-!B at the level of subunit phosphorylation
(Shapira et al., 2002) and nuclear translocation of this transcription factor (Butcher and
Denkers, 2002; Butcher et al., 2001), associated with reduced production of IL-12. Other
studies have shown that in vivo administration of soluble Toxoplasma antigens (STAg)
induces a state of refractoriness in dendritic cells, rendering them incapable of producing
IL-12 after subsequent pathogen challenge (Reis e Sousa et al., 1999), potentially via its
interference with the MAPK pathway (Kim et al., 2004). Further, T. gondii is also known
to promote sustained activation of STAT3, causing suppression of TNF-# and IL-12
(Butcher et al., 2005b), while at the same time inhibiting nuclear translocation of STAT1
(Luder et al., 2001). The fact that T. gondii interferes with multiple signaling pathways
14

associated with innate recognition and anti-parasitic effector mechanisms indicates the
importance of these pathways in limiting early parasite growth and replication.
Numerous studies have indicated that the pro-inflammatory cytokine IL-12 plays
a key role in the response to Toxoplasmosis (Gazzinelli et al., 1993; Gazzinelli et al.,
1994; Hunter et al., 1995b; Khan et al., 1994). Once IL-12 was recognized as being
critical for resistance to T. gondii, subsequent studies focused on identifying the source of
this cytokine during infection, and a number of innate cell types were shown to produce
IL-12 in response to T. gondii. A population of inflammatory neutrophils that have the
ability to rapidly produce IL-12 has been shown to traffic to the site of infection (Bliss et
al., 2000; Bliss et al., 2001). Macrophages are also important in the acute response to T.
gondii and have been ascribed diverse functions including antigen presentation, IL-12
production, parasite phagocytosis and production of reactive nitrogen intermediates.
Dendritic cells, which also produce IL-12 in addition to other pro-inflammatory
cytokines, have been shown to play an important role in the immune response to T.
gondii (Liu et al., 2006). Hours following injection with STAg, IL-12p40-producing DCs
can be found in the spleen (Aliberti et al., 2000). The plasmacytoid DC subset has been
found to be activated as well as produce IL-12 following T. gondii infection, and is
implicated in antigen presentation to CD4+ T cells (Pepper et al., 2008).
In addition to skewing the differentiation of naïve T cells toward a Th1
phenotype, IL-12 can also influence the activation and effector function of other cell
populations including natural killer (NK) cells, which are an important component of the
innate response to T. gondii. Very early studies showed that injection of antigen
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preparations of T. gondii or infection lead to increased NK cell activity (Hauser et al.,
1982; Hauser et al., 1983; Sharma et al., 1984). Studies in SCID mice, which lack all B
and T cells, demonstrated the expansion of a substantial NK cell response following T.
gondii infection. This population expanded and produced the IFN-" required for survival
of the acute phase of infection (Hunter et al., 1994; Sher et al., 1993). Mice lacking MHC
class I-restricted CD8+ T cells also demonstrated an expansion of NK cells following T.
gondii infection, and these cells were a considerable source of IFN-" following in vitro
restimulation of splenocytes (Denkers et al., 1993b).
The events that lead to the production of IFN-" have a critical role in promoting
resistance to T. gondii, and a number of studies document the importance of this cytokine
during the acute stage of infection as well as in preventing reactivation of latent disease
(Scharton-Kersten et al., 1996; Schofield et al., 1987; Suzuki et al., 1989; Suzuki et al.,
1988; Torrico et al., 1991). The importance of IFN-" in helping control this pathogen has
been recognized for more than 30 years, and we continue to gain better understanding of
its regulation of anti-parasitic effector mechanisms including reactive oxygen
intermediates (ROI) and interferon-"-inducible GTPases (Collazo et al., 2001; SchartonKersten et al., 1997; Taylor et al., 2000). The immunity-related GTPases (or IRGs) are
interferon-"-inducible proteins, at least 6 of which are required for resistance to infection
with T. gondii (Zhao et al., 2009), and following infection these proteins are recruited to
the membrane of the parasitophorous vacuole (Butcher et al., 2005a), but these more
recent studies have also highlighted our limited knowledge of parasite killing
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mechanisms. This innate response from NK cells, DC and other antigen-presenting cells
is a critical link that allows the development of adaptive immunity.

1.4.2 Adaptive Immunity to T. gondii
While infection with T. gondii elicits a strong innate response that provides an
early mechanism of resistance, the long-term control of this organism is dependent on the
development and maintenance of parasite-specific adaptive immunity. Challenge with
this parasite leads to the sustained production of T. gondii-specific antibodies by B cells,
and T cells that exert effector functions including cytokine production and cytoxicity.
The adaptive immune response has the additional benefit of maintaining memory
responses against pathogens it encounters. In this section, we will discuss the role that
adaptive immune cells and their effector functions play in the response to T. gondii.
Infection with T. gondii leads to an expansion of the B cell compartment and
subsequent production of parasite-specific antibodies, and it was recognized almost 40
years ago that transfer of sera from immune mice could provide some protection to naive
mice (Krahenbuhl 1972). The Sabin-Feldman dye test used for detection and
quantification of T. gondii-specific serum antibodies is dependent on the ability of
antibodies to cause complement-dependent lysis of tachyzoites (Schrieber RD 1980). The
role of B cells during T. gondii infection was later studied in B cell-deficient (µMT)
mice. While these mice were able to survive the primary phase of infection, they
succumbed early in the chronic stage (Kang et al., 2000). The ability of µMT mice to
gain protection following vaccination was dependent on the parasite strain used to
challenge them. While µMT mice could resist a Type II strain they, were not able to
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survive challenge with the more virulent Type I strain (Johnson et al., 2004; Sayles et al.,
2000), and while transfer of immune sera to µMT mice delayed time to death following
T. gondii challenge it did not allow them to survive (Johnson et al., 2004). Together,
these studies indicate that B cells and antibody contribute to immunity against T. gondii
by providing a mechanism for parasite killing via antibody-mediated lysis. Nevertheless,
B cells are also known to present antigen and produce cytokines, for instance surface
TNF-# on B cells can help enhance IFN-" production by T cells (Menard et al., 2007),
but little is known about these other functions of B cells during Toxoplasmosis.
As discussed in the previous section, NK cells provide a limited mechanism of
resistance to T. gondii. The importance of T cells in the long-term control of T. gondii is
perhaps best illustrated by the observation that patients with primary or acquired defects
in T cell function are susceptible to reactivation of latent bradyzoites and suffer effects in
the CNS (Luft et al., 1984). Understanding the contribution of each T cell subset was
made possible through experiments using animal models. The transfer of T cells from
immunized mice to naïve mice could provide protection against a lethal challenge of T.
gondii, but this was abolished by depletion of CD8+ T cells prior to transfer (Parker et al.,
1991; Suzuki and Remington, 1988). Similarly, transfer of CD8+ T cells from chronically
infected mice to naïve WT or nude mice was able to provide protection from T. gondii
challenge (Parker et al., 1991). These studies were supported by others demonstrating
that H2 haplotype profoundly influenced the outcome of infection (Brown and McLeod,
1990; Suzuki et al., 1994), and that CD8+ T cells were the major source of IFN-" in vivo
during infection (Gazzinelli et al., 1991; Shirahata et al., 1994). Therefore, a major focus
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of this thesis is the generation as well as maintenance of a CD8+ T cell response to T.
gondii.
As CD8+ T cells are known to exert their effector functions primarily via cytokine
production or cytolytic activity, studies were performed to define the contribution of
these pathways to control of T. gondii. Early reports demonstrated that CD8+ T cells
isolated from immunized or infected mice were capable of lysing infected cells or targets
pulsed with parasite antigens (Denkers et al., 1993a; Hakim et al., 1991; Khan et al.,
1991; Subauste et al., 1991). Initial studies with perforin-deficient mice revealed that they
were less susceptible to infection than CD8-deficient mice, and could generate a
protective CD8+ T cell response. However, these mice showed increased susceptibility to
chronic Toxoplasmosis, indicating that the ability to recognize and lyse infected cells was
required for optimal resistance (Denkers et al., 1993b; Denkers et al., 1997). The analysis
of cytolytic activity frequently relied on the in vitro expansion of rare T cell populations
and the use of chromium release assays to demonstrate lytic activity. An in vivo
cytotoxicity assay has been developed and has proven useful in detecting cytolytic
responses induced by viral infection models (Barber et al., 2003) and more recently in the
T. cruzi infection model (Martin and Tarleton, 2005). Chapter 3 will describe how a
similar approach was developed to measure cytolytic activity to T. gondii.
Many factors are known to influence the generation of CD8+ T cell responses,
including cytokines such as IL-2 and IL-12, which contribute to T cell expansion,
survival, and the acquisition of effector function. At the time when these studies were
initiated, some work had been undertaken to understand the antigen-specific CD8+ T cell
response during chronic Toxoplasmosis (Kwok et al., 2003; Lutjen et al., 2006). In more
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general terms, less was known about CD8+ T cell memory responses to most chronic
infections. Many parasites form persistent infections for the life of the individual,
associated with on-going antigen exposure (Frenkel, 1988; Zhang and Tarleton, 1999).
This makes it hard to define memory, as compared to memory CD8+ T cells induced by
acute viral infection where the kinetics of pathogen burden and clearance are better
defined (Joshi et al., 2007). The phenotype of cells induced following T. gondii infection,
how this differs from what is seen during acute viral infection, and the consequences in
terms of memory formation, will be further discussed in Chapter 3.
CD4+ T cells were demonstrated to play a contributory role in resistance to T.
gondii, but were not as critical as CD8+ T cells in conferring resistance (Gazzinelli et al.,
1991; Parker et al., 1991). Early work focused on the protective role that CD4+ T cells
could play in preventing reactivation of latent disease in the brain (Vollmer et al., 1987).
CD4+ T cells are the main producers of the T cell growth factor IL-2, and might be
playing other helper-like roles for CD8+ T cells or other cell populations during infection.
Studies with CD4-deficient mice demonstrated that CD4+ T cells were required to
maintain CD8+ T cell responses against chronic T. gondii, as demonstrated by a precursor
CTL assay (Casciotti et al., 2002). While this thesis work was already underway, the
Schlüter laboratory made use of a transgenic parasite to show that CD4+ T cell help
contributed to antigen-specific CD8+ T cell function in the brain but not the spleen
(Lutjen et al., 2006). Beyond their role in IFN-" production, it was also known that CD4+
T cells contributed to the antibody response to infection (Araujo, 1991). It is now well
understood that that a particular subset of CD4+ T cells called follicular helper cells is
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responsible for interacting with B cells to induce their expansion, class switching, and
germinal center formation (Kim et al., 2001; Schaerli et al., 2000).
In addition to the protective function they can play during infection, CD4+ T cells
have sometimes been shown to play a pathological role during T. gondii infection of the
central nervous system (Israelski et al., 1989; Stumhofer et al., 2006; Wilson et al., 2005).
Part of the difficulty of interpreting the role of CD4+ T cells during T. gondii is that
different strains of mice demonstrate diverse outcomes, something that has been known
for some time (Araujo et al., 1976). Additionally, there are clear instances where CD4+ T
cells can play pathological roles in the intestine, dependent on IFN-" production, which
differs between C57BL/6 and BALB/c mice (Liesenfeld et al., 1996). The importance of
tight regulation of the immune response to control parasite replication while limiting
damage to the host will be discussed in the next section.

1.4.3 Regulation of immune-mediated pathology during T. gondii
The immune response to T. gondii is highly Th1 polarized and characterized by
the systemic production of pro-inflammatory cytokines, and consequently must be
carefully controlled to prevent immune-mediated pathology in the host. While all of the
factors that contribute to limiting the inflammatory response to T. gondii will not be
discussed here, a few major findings as they relate to the immune biology of
toxoplasmosis will be highlighted. As mentioned above, CD4+ T cells have a complicated
role in response to this infection and can contribute to immunopathology, which is
partially dependent on host genetic background. Immunoregulatory cytokines,
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specifically IL-10 and IL-27, are important in limiting the pro-inflammatory responses of
CD4+ T cells and limiting the pathological effects. Early experiments where SCID mice
were treated with antibodies against IL-10 demonstrated a prolonged survival of these
mice during acute T. gondii infection (Hunter et al., 1993), consistent with the idea that
IL-10 is antagonist of protective innate responses. However, when T cell-sufficient IL-10/-

mice were infected with T. gondii, they experienced a lethal inflammatory response that

was driven by overproduction of IFN-" by CD4+ T cells, as well as TNF-# and IL-12 by
splenic macrophages (Gazzinelli et al., 1996). IL-10-/- mice also have increased levels of
pro-inflammatory cytokine production and immune pathology in the brain during chronic
infection (Wilson et al., 2005). It was later found that CD4+ Th1 cells induced during T.
gondii infection were capable of simultaneously producing IL-10 as well as IFN-", and
that this population of cells was important in limiting IL-12 production by APCs
(Jankovic et al., 2007). Together, these findings indicate that regulation of the
inflammatory response by IL-10 is critical for maintaining the balance of immunity vs.
pathology.
Whereas IL-10 inhibits Th1 responses through its effects on APCs, transforming
growth factor-$ (TGF-$) has direct inhibitory effects on Th1 cells. TGF-$ can also act to
inhibit IL-12-induced pro-inflammatory cytokine production by NK cells (Hunter et al.,
1995a). When TGF-$ was neutralized following T. gondii infection, normally resistant
mice suffered from acute inflammation and necrosis of the gut tissue (Buzoni-Gatel et al.,
2001). Another more recently described cytokine, IL-27, has also been show to
downregulate the inflammatory responses induced during toxoplasmosis. This cytokine is
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specifically important in limiting host pathology induced by IFN-" (Villarino et al., 2003)
as well as IL-17 (Stumhofer et al., 2006). Overall, these studies illustrate some of the
pathways that act to balance the immune system as it attempts to combat invading
pathogens, especially in the context of chronic infection.

1.2 NF-!B in Immunity
The nuclear factor-!B (NF-!B) family is an evolutionarily conserved and
ubiquitous family of transcription factors present in many species, from Drosophila to
mice to humans. This section will introduce these transcription factors, focusing on their
role in immune cell development and function. The Hunter laboratory has had a longstanding interest in how this family of transcription factors regulates innate and adaptive
immunity to T. gondii, and for my thesis work I focused on the one subunit that is
expressed only in immune cells, c-Rel, and how this transcription factor contributes to the
development of protective CD8+ T cell responses.

1.2.1 Introduction to NF-!B: Signaling
There are five different members in the mammalian NF-!B family of
transcription factors, belonging to different classes, which are either synthesized as
mature products (Rel A, Rel-B and c-Rel) or which must first undergo proteolytic
processing (p105/p50 and p100/p52). Inactive NF-!B molecules are held in the
cytoplasm through association with inhibitory members of the I!B family, which consists
of 7 members (I!B#, I!B$, I!B%, I!B", Bcl-3, and the p100 and p105 precursor proteins)
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(Hayden et al., 2006). The I!B and NF-!B molecules interact via the Rel homology
domain present on NF-!B proteins, which contains the nuclear localization sequence
required for entry to the nucleus upon activation. NF-!B family members are expressed
in every cell type and control numerous pathways involved in responses to infection,
inflammation and injury (Gilmore, 2006). Because of the extensive list of factors able to
induce NF-!B activation, signaling via this pathway is highly regulated and dysregulated
function has been associated with abnormal cellular proliferation and lymphomas (Jost
and Ruland, 2007). NF-!B signaling can occur via either a classical or a non-canonical
pathway depending on the activating stimulus. Classical NF-!B signaling is mediated by
the p50, c-Rel and RelA subunits, and is typically induced by T or B cell antigen receptor
signaling, co-receptor activation, cytokines including TNF-# and IL-1, or TLRs (Figure
3). The non-canonical NF-!B signaling pathway uses the p52 and Rel-B subunits, and is
activated by a specific set of stimuli that includes CD40L, BAFF (B cell Activating
Factor) and Lymphotoxin-$.
Different NF-!B family members may serve overlapping roles in certain
situations but non-redundant roles in others, complicating the study of their function. For
instance, deletion of Rel A is embryonic lethal due to TNF hypersensitivity in the liver
(Beg et al., 1995). p50 is also widely expressed, and its deletion leads to decreased
generation of marginal zone as well as peritoneal B cells, as well as defective Th1 and
Th2 responses (Artis et al., 2005; Cariappa et al., 2000; Grumont et al., 1998; Harris et
al., 2010; Sha et al., 1995). Mice lacking Rel B are missing certain dendritic cell
populations and are unable to form lymph node or Peyer’s patch structures(Burkly et al.,
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1995; Weih et al., 2001). Table 1 summarizes the susceptibility of different NF-!B
knockout mice in a variety of infectious and inflammatory settings; these findings
indicate that while some commonalities may be found between the 5 NF-!B family
members, each can also play distinct roles.

1.2.2 c-Rel in immune cell development and function
Though different NF-!B family members have also been shown to be involved in
a variety of cellular processes in diverse cell types including neurons, hepatocytes and
osteoclasts, for the purposes of this thesis I will now focus on c-Rel. c-Rel was first
identified as a proto-oncogene closely related to the avian Rel gene known to induce
lymphomas in birds (Moore and Bose, 1988; Moore and Bose, 1989). Unlike other NF!B family members, the expression of c-Rel is mainly limited to the immune system, in
lymphoid and myeloid populations (Brownell et al., 1987; Simek and Rice, 1988). Early
studies in c-Rel-/- mice indicated that although major immune cell populations could
develop normally, lymphocytes showed major defects in antigen-induced activation,
proliferation and effector function (Kontgen et al., 1995; Tumang et al., 1998). While cRel is required for antigen-driven proliferation of B cells, it does not appear to affect their
lymphopenia-induced homeostatic expansion (Cabatingan et al., 2002), suggesting that
cytokine-driven proliferation is regulated differently than mitogen-induced proliferation.
c-Rel has also been demonstrated to play an important role in the development of
marginal zone B cells (Cariappa et al., 2000), as well being required for isotype class
switching (Harling-McNabb et al., 1999; Zelazowski et al., 1997). c-Rel is also
associated with the inhibition of apoptosis, and accordingly the pro-survival molecule
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Table 1. Phenotype of single gene NF-!B knockout mice: role in immune cells and
during pathogen challenge. Unless otherwise noted, data refer to experiments conducted
in single gene knockout mice.
Deficiency

Functional abnormalities

Susceptibility to infection

NF-!B1 (p50)

B cell proliferation and isotype
switching;

Increased susceptibility to:
Leishmania major, Trichuris muris,
Entamoeba histolytica

NF-!B2 (p52)

Peyer’s patch and germinal center
formation;

Increased susceptibility to: L.
major, T. muris, T. gondii

RelB

Germinal center formation and
lymph node architecture; thymic
atrophy; splenalomegaly

Increased susceptibility to: T.
gondii, Listeria monocytogenes,
LCMV

c-Rel

B and T cell proliferation and
effector function; isotype
switching

Increased susceptibility to: T.
gondii, L. major, L. monocytogenes

Macrophage nitric oxide

Increased susceptibility to: L. major

Rel-A
(chimeras)
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Not required for resistance to: T.
muris, influenza virus

Bcl-xL was shown to be a target of c-Rel in B cells (Owyang et al., 2001). In summary,
these studies indicate a major role for c-Rel in the generation, survival and function of B
lymphocytes. While biochemical studies have revealed direct binding by c-Rel to the
promoters of a subset of genes in T cells, it is thought that the expression of other genes
including IL-5, IFN-" and TNF-# are affected indirectly. One potential mechanism that
explains this outcome is the suboptimal production of IL-2 by c-Rel-/- CD4+ T
lymphocytes, and the correspondingly poor proliferation of T cells in the absence of this
growth factor. In T cells, however, this defective proliferation, as well as production of
some cytokines, could be rescued with exogenous IL-2 (Gerondakis et al., 1996; Liou et
al., 1999). Consistent with these early studies, IL-2 was later shown to be a c-Rel target
gene that is activated following binding of c-Rel to the CD28 response element in T cells
(Huang et al., 2001). Recent gain-of-function and loss-of-function experiments in CD4+ T
cells found that none of the genes studied showed a complete dependence on c-Rel, rather
its presence or absence influenced the expression levels of target genes depending on the
context (e.g. cell type or activating stimulus) (Bunting et al., 2007).
c-Rel is also present in accessory cell compartments and several defects have been
described. In macrophages, c-Rel has been shown to bind to the IL-12p40 promoter
following LPS stimulation (Sanjabi et al., 2000). However in DC, c-Rel specifically
induces IL-12p35 transcription, indicating that c-Rel has differential effects on cytokine
production, depending on cell type (Grumont et al., 2001). Despite this defect in the
ability of c-Rel-/- accessory cells to produce IL-12, mice infected with T. gondii could
overcome this block and produce IL-12 independently of c-Rel (Mason et al., 2002). In
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another study, bone marrow-derived DC were also found to be impaired in the production
of IL-23 p19 (Carmody et al., 2007a), which is likely why c-Rel-/- mice are resistant to
the development of colitis induced by Helicobactor hepaticus or by transfer of
CD4+CD45RBhi T cells (Wang et al., 2008). In addition to regulating cytokine production
in innate immune cells, c-Rel also influences the function of some APCs. A specialized
subset of DC called plasmacytoid DC was reduced two-fold in c-Rel-/- mice, and these
cells also had specific defects in production of IL-12p70 (O'Keeffe et al., 2005).
Additionally, c-Rel-/- DCs had a defect in their ability to cross-present antigen in a model
where mice were immunized with irradiated OVA-pulsed splenocytes (Mintern et al.,
2002). The possibility that cross-presentation was impaired following immunization with
T. gondii will be discussed further in Chapter 4.
In the context of infection studies with c-Rel-/- mice, the absence of this
transcription factor contributes to increased susceptibility to some but not all pathogens.
For instance, immunity to T. muris is not affected in c-Rel-/- mice, indicating that this
transcription factor is not essential for the generation of Th2 immunity (Artis et al.,
2002). Immunity to influenza infection also seems minimally affected by the loss of c-Rel
because clearance of virus during acute infection, which is mediated by CD8+ T cells,
was only slightly delayed (Harling-McNabb et al., 1999). In contrast, Th1-mediated
immunity to other pathogens including T. gondii and L. major is severely compromised
in c-Rel-/- mice (Grigoriadis et al., 1996; Mason et al., 2004b). However, loss of c-Rel can
also lead to resistance against Th1-mediated immune pathology. When c-Rel-/- mice
received H-2 mismatched islet allografts, they had increased survival of transplanted
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tissue in comparison to WT mice, associated with decreased infiltration of the graft and
depressed T cell responses (Yang et al., 2002). c-Rel-/- mice are also resistant to the
development of diabetes (Lamhamedi-Cherradi et al., 2003). In humans, over-expression
of c-Rel has been linked with malignancies (Houldsworth et al., 1996; Lu et al., 1991),
systemic lupus erythematosus (Burgos et al., 2000) and more recently with rheumatoid
arthritis (Dieguez-Gonzalez et al., 2009; Eyre et al., 2009; Gregersen et al., 2009). While
clearly the role of c-Rel during a coordinated immune response is complex, a model
illustrating immunity to T. gondii and the aspects during this response where c-Rel is
implicated is shown in Figure 4.
In the following chapters, my thesis work looking at CD8+ T cell responses to T.
gondii will be presented. While much is known about the regulation of CD8+ T cell
responses to infection in different models, unanswered questions remained in areas
related to the influence of the inflammatory environment on the development of T cell
responses, and in the development and maintenance of memory during parasite infection.
This introduction was meant to highlight the complex biology of T. gondii infection, and
also the complicated nature of the immune response and some of the many factors that
regulate the responses of different immune cell subsets. My thesis work will demonstrate
the development of adaptive immunity to a replication-deficient parasite strain and
discuss the role of the inflammatory environment, specifically the key contributions of
the cytokine IL-12. Additionally, I will focus on the NF-!B family member c-Rel and its
role in supporting CD8+ T cell development, and hypothesize about its role in T cell
memory.
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Chapter 2 : Materials and Methods

Mice
C57BL/6, Thy1.1, C57BL/6-Prf1tm1Sdz/J (Kagi et al., 1994) and B6.MRL-Faslpr/J mice
(Andrews et al., 1978) were purchased from Jackson Laboratory (Bar Harbor, Maine). In
some experiments C57BL/6 and Thy1.1 mice were purchased from NCI (Frederick, MD).
B6.SJL-Ptprca/BoyAiTac (CD45.1) mice were purchased from Taconic. c-Rel-/- mice
were originally obtained from H.C. Liou (Weill Medical College of Cornell University,
New York, NY) (Tumang et al., 1998) and were bred at the University of Pennsylvania.
B6[TG]TCR-OT-1 RAG1[KO] (Hogquist et al., 1994; Mombaerts et al., 1992) were
obtained through the NIAID Exchange Program (Taconic line 4175). DPE-GFP
transgenic mice, which express GFP in all T cells, were originally obtained from U.H.
von Andrian (CBR, Harvard, Boston MA) and were crossed to OT1 TCR transgenic
mice, resulting in OT1 transgenic TCR that express GFP (OT1-GFP) (Mrass et al., 2006).
All mice were maintained under specific pathogen-free conditions and all animal work
was done in accordance with the Institutional Animal Care and Use Guidelines of the
University of Pennsylvania.

Parasites and Infections
Tachyzoites were grown in human foreskin fibroblast monolayers in Dulbecco modified
Eagle medium containing either 1% FCS (CPS and RH parasites) or 10% FCS (Pru
parasites), and 1% penicillin-streptomycin. CPS parasites were cultured in media
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containing 0.2 mM uracil, and ovalbumin-transgenic parasites were maintained in media
additionally containing 20 µM chloramphenicol. For all immunization experiments using
CPS-OVA, mice were injected intraperitoneally (i.p.) with 105 parasites. For challenge
experiments, mice were given 103 RH-OVA tachyzoites (RH parental strain expressing
secreted ovalbumin) or 106 CPS-OVA. For all adoptive transfer experiments, mice
received 105 Pru-OVA tachyzoites i.p.

T cell Depletions and Transfers
For T cell depletion experiments, mice received two doses of 0.5 mg of anti-CD4 (clone
RM4.5) or anti-CD8 (clone 2.43) in the week prior to challenge. For depletion of IL-12,
mice received two injections of anti-IL12p40 (clone C17.8) on day -1 and day 2 of
immunization. For rescue of antigen-specific responses, c-Rel-/- mice received 3
intraperitoneal (i.p.) injections containing 500 ng of recombinant IL-12p70 (eBioscience)
on days 0, 1 and 2 of infection. For adoptive transfer experiments, splenic and lymph
node T cells were isolated via negative selection (R&D Systems, Minneapolis, MN);
mice received 5 x 105 WT or c- Rel-/- OT1 cells that were transferred into recipient mice
intravenously via retro-orbital injection 24 hours prior to challenge. For assessment of
memory responses, T cells were isolated 30 days following immunization and 107
immune cells were transferred intravenously one day prior to secondary challenge. Mice
were anesthetized with isoflurane prior to intravenous injection.

In vitro T cell responses
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Mice were sacrificed by CO2 asphyxiation. Spleen, lymph node (LN) and peritoneal
exudate cells (PECs) were harvested and dissociated into single cell suspensions in
complete RPMI 1640 (Gibco/Invitrogen, Carlsbad, CA) containing 10% heat-inactivated
FCS, 10 U/ml penicillin, 100 µg/ml streptomycin, 2mM glutamine, 25 mM HEPES, 0.1
mM non-essential amino acids and 50 µM 2-beta mercaptoethanol (2ME). For analysis of
peripheral blood mononuclear cells, blood was collected and mixed with sodium citrate
prior to lysis of erythrocytes with 0.86% ammonium chloride buffer. Spleen and LN cells
(5&105/well) and PECs (105/well) were plated out in triplicate in 96-well round bottom
plates (Costar, Carlsbad, CA) and cultured to assess for cytokine production. Cells were
restimulated with anti-CD3 (1 µg/ml), soluble T. gondii antigen (STAg; 10-25 µg/ml),
500 µg/ml OVA (Worthington Biochemical Corporation, Lakewood, NJ) or 1µg/ml OVA
peptide (SIINFEKL) (CHI Scientific, Maynard, MA). Supernatants were removed after
approximately 48 hours and assayed for the production of IFN-" by enzyme-linked
immunosorbent assay (ELISA) as previously described.

Acute IL-12 Responses
For assessment of acute IL-12 production, WT and c-Rel-/- mice were infected as noted
above. At 72 hours following challenge, whole blood was collected and incubated at
room temperature prior to centrifugation for 10 min at 14,000 RPM to facilitate serum
isolation. Serum was assayed for IL-12p70 as well as IL-12p40 by ELISA. PECs were
collected and plated out at 106 cells/well, and incubated for 24 hours in the absence of
additional antigen stimulation. IL-12 levels were then assessed by ELISA.
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B3Z Antigen Presentation assay
Splenic dendritic cells (DC) were isolated from WT and c-Rel-/- mice, at 4 days postinfection with 104 Pru-OVA parasites. Cells were sorted by staining the cell suspension
with CD11c microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany), and selection
of the DC subset occurred by running the cell suspension through an LS column
(Miltenyi). The B3Z cells have been described previously (Karttunen et al., 1992). This
hybridoma cell line expresses a $-galactosidase reporter that becomes active following
TCR stimulation, and its TCR is specific for ovalbumin. Titrated numbers of DC from
naïve or infected WT and c-Rel-/- mice were plated out in medium without phenol red.
B3Z cells were added in the absence of exogenous antigen. $-galactosidase activity was
detected by adding chlorophenol red-$-D-galactopyranoside (CPRG; Calbiochem, San
Diego, CA) at a final concentration of 100 µM, and absorbance was measured at 562 nm.
Activation was expressed as increase in absorbance, relative to values obtained in the
absence of antigen, as described previously (Dzierszinski et al., 2007).

Flow cytometry
For identification of OVA-specific T cell responses, single-cell suspensions were washed
in FACS buffer (PBS, 2 mM EDTA, 2% BSA) and incubated for 15 minutes with Fc
block (FACS Buffer containing 1 µg/ml 2.4G2 (BD Pharmingen, San Jose, CA) and 1
µg/ml rat and mouse IgG (Caltag)). Cells were stained with MHC class I/tetramer
complexes of H-2Kb/SIINFEKL conjugated to phycoerythrin (PE) or allophycoerythrin
(APC) (Beckman Coulter Immunomics, or generous gift from John Wherry (Wistar
Institute, Philadelphia PA)) for 25 minutes at room temperature. The cells were then
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washed and stained for other surface markers for 15 minutes at 4° C. Naïve mice were
used as controls to assess levels of background staining obtained with the tetramer. The
following monoclonal antibodies were used for phenotypic staining: CD8 (conjugated to
fluorescein (FITC,) Peridinin Chlorophyll Protein Complex (PerCP) or APC), CD127biotin, CD122-biotin, CD62L-APC or APC Alexa fluor 700 (BD Biosciences); TNF-#
FITC, IFN-"-APC, IL-2 PE, KLRG1-APC, Streptavidin-APC (eBioscience, San Diego,
CA); anti-human Granzyme B-APC (Caltag, Carlsbad, CA).

For intracellular cytokine analysis, splenocytes or PECs were incubated (cell and antigen
concentration as noted above) for 5.5 hours total, with the addition of 10µg/ml Brefeldin
A (Sigma) for the final 4 hours. Cells were first stained for surface markers, followed by
fixation overnight with 2% PFA (Electron Microscopy Sciences, Hatfield, PA). Cells
were permeabilized with 0.1% saponin and then stained for intracellular cytokines for 1
hour at 4°C. Flow cytometry samples were collected on a FACSCalibur or FACSCanto
machine (BD) and analyzed with FlowJo software (Tree Star Inc. Ashland, OR).

In vivo CTL assay
Cytolytic activity was assessed using the in vivo CTL assay, modified slightly from
previous protocols (Barber et al., 2003). Briefly, spleen and LN cells from CD45.1 mice
were pooled and pulsed with 1 µg/ml OVA peptide (CHI Scientific) for 1hour at 37°C.
Cells were washed extensively in PBS, labeled with CFSE (Molecular Probes/Invitrogen)
at a concentration of 5µM (cells pulsed with OVA peptide) or 0.1µM Carboxyfluorescein
succinimidyl ester (CFSE) (unpulsed cells). Cells were then counted and resuspended at a
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1:1 ratio. 6x106 total cells (3x106 peptide-pulsed and 3x106 unpulsed) were then
transferred intravenously to anesthetized recipient mice. Mice were sacrificed 4-24 hours
later and spleens were analyzed for specific lysis of the peptide-pulsed population by
flow cytometry by gating on CD45.1+ donor cells. Specific lysis was calculated as
described previously (Barber et al., 2003). A diagram of the lysis assay and calculation of
lysis activity is shown below in Figure 5.

Statistics
Statistical analyses were completed with Prism (Graphpad Software, La Jolla, CA) using
Student’s t test, or one-way ANOVA where indicated. Where appropriate, data are shown
as mean ± standard deviation. The Kaplan-Meier test was used to measure significant
differences between survival curves of naïve versus immunized c-Rel-/- mice, and
unmanipulated versus T cell-depleted immune mice following RH-OVA challenge.
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Chapter 3: The CPS-OVA Model System
3.1 Introduction to the CPS-OVA system
While much has been learned about the factors that lead to protective immunity to
T. gondii, relatively little is known about what is required for optimal generation of
antigen-specific T cell responses. To better define some of the factors that lead to
protective immunity and the development of antigen-specific CD8+ T cell memory, a
system had to be developed to enable long-term tracking of infection-induced
populations. Therefore, in collaboration with colleagues in the Department of Biology,
Type I (RH) and Type II (Pru) strains of T. gondii that secreted the model antigen
ovalbumin (OVA) were generated (Dzierszinski et al., 2007; Pepper et al., 2004). The
Pru-OVA parasite was used in studies by the Hunter laboratory to show the activation
and expansion of adoptively transferred transgenic CD4+ T cells. It was soon realized that
endogenous CD8+ T cell responses were also induced by parasite secretion of the model
antigen OVA, and that these responses could be tracked using MHC Class I/OVA
tetramers.
The aim of the work presented in this chapter was to create better understanding
of how the adaptive immune response to T. gondii is generated, which will be helpful for
the development of an effective vaccine. Various T. gondii protein or DNA vaccines have
been tested in mice and have provided varying levels of protection (Scorza et al., 2003;
Yap et al., 1998). Perhaps the most effective protection against T. gondii has been
provided by infection with an attenuated temperature-sensitive strain of parasite called ts39

4; however, this strain possesses the ability to replicate and cause disease in immunodeficient as well as immunocompetent hosts and so could not be used in humans (Sayles
and Johnson, 1996). A possible solution to this safety issue is to genetically modify
parasites so they are unable to replicate in vivo, and would be incapable of reverting to a
virulent phenotype. One such clone was generated by knocking out a regulatory enzyme
of the de novo pyrimidine biosynthesis pathway, carbamoyl phosphate synthetase (cps)-II
(Fox and Bzik, 2002), a mutation that renders the parasites unable to replicate in the
absence of exogenous uracil. The cps-II strain is therefore non-virulent in mice; even
mice that lack IFN-" survive infection with this organism (Fox and Bzik, 2002). Further,
immunization with cps-II protects WT mice following challenge with the virulent RH
strain (Fox and Bzik, 2002). At the time these studies were initiated, however, little was
known about the nature of the adaptive immune response that these parasites induced.
Consequently, to allow the tracking of an endogenous CD8+ T cell population, the cps-II
parasites were engineered to express a secreted form of the model antigen ovalbumin
(hereafter referred to as CPS-OVA).
The experiments presented here examine the kinetics, phenotype and function of
endogenous antigen-specific CD8+ T cells generated in response to the CPS-OVA
parasites. Immunization-induced protection required T cells at the time of challenge, and
the CD8+ T cell subset was most protective. The peak of CD8+ T cell expansion to CPSOVA was seen at day 10 in both the site of infection as well as secondary lymphoid
tissues. Unexpectedly, despite being replication-deficient, these parasites induced an
OVA-specific response that was comparable in magnitude and more rapid than that
observed using a replicating parasite, Pru-OVA. Optimal generation of the antigen40

specific cells in response to CPS-OVA required the presence of CD4+ T cells at the time
of immunization. Nonetheless, the CD8+ T cells that were generated in the absence of
CD4+ T cell help were able to produce IFN-" and were cytolytic. CD4+ T cell help also
was critical for the upregulation of the killer-like lectin receptor G1 (KLRG1) on CD8+ T
cells, a marker upregulated by effector T cells in a number of infection models (Blaser et
al., 1998; Joshi et al., 2007; Robbins et al., 2003). Cytolytic activity was mediated mainly
via a perforin-dependent pathway while Fas-FasL interactions were not required. This
work provides some of the first data regarding the phenotype and function of antigenspecific cells induced by a non-replicating strain of T. gondii, and suggests that an
effective vaccine targeting cell-mediated immunity should engage both CD4+ and CD8+
T cell subsets.

3.2 T cells are required for CPS-OVA induced protective immunity
Earlier work demonstrated that cps1-1 parasites could provide protective
immunity to challenge with the virulent RH strain of T. gondii (Fox and Bzik, 2002).
However, these studies did not provide an analysis of the adaptive immune response to
immunization, or indicate which cell types were important for protection. In order to
define which T cell subsets were required for CPS-induced protective immunity, mice
were injected intraperitoneally with a single dose of 105 CPS-OVA parasites, and 30 days
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later were challenged with the virulent Type I strain RH-OVA (or the parental strain
lacking expression of OVA, RH). Unimmunized mice succumbed to RH-OVA infection
by day 12, while mice immunized with CPS-OVA survived this challenge (Figure 6). To
clarify whether or not T cells were important for this protection, immunized mice were
depleted of either CD4+ or CD8+ T cells one week prior to RH-OVA challenge. Depletion
of CD8+ T cells resulted in increased susceptibility to RH-OVA challenge (p = 0.0032 by
one-way ANOVA), while CD4+ depletion had only a minor effect on survival (Figure 6).
Thus, in this model of immunization with a single dose of 105 CPS-OVA parasites, while
both CD4+ and CD8+ T cells contributed to resistance to challenge, CD8+ T cells
provided the most protection. As shown in Figure 6, CPS-OVA immunization was also
able to provide resistance to challenge with the parental strain (RH), indicating that CPSOVA induces a polyclonal response that is not completely targeted toward OVA.

3.3 Immunization with a replication-deficient parasite induces a robust
endogenous CD8+ T cell response and upregulation of activation markers
Because the parasite used in these experiments expressed the model antigen OVA,
studies were performed to determine if we could track the endogenous CD8+ T cell
response using an OVA-specific MHC Class I tetramer. These experiments revealed that
OVA-specific cells could be readily detected as early as 5 days following immunization,
though as a proportion of the CD8+ T cell population the frequency of OVA-specific
CD8+ T cells was much higher in the PECs (Figure 7D) compared to the spleen (Figure
7B). Kinetic analysis indicated that the peak of this response occurred 10 days postinfection, after which point it declined, though low numbers of OVA-specific cells were
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maintained at least 30 days in these sites (Figure 7A, C). Though the magnitude of OVAspecific CD8+ T cells peaked at day 10 in both sites, the antigen-specific population
contracted more slowly in the PECs than in the spleen.
The use of tetramers to identify the OVA-specific CD8+ T cell population allowed
us to analyze the expression of phenotypic markers including CD62L, KLRG1, CD122
and CD127 on parasite-specific cells. We found that at day 7, the majority of tetramer+
cells in the spleen had upregulated KLRG1 and had downregulated CD62L (Figure 8, top
panel), thus exhibiting an effector phenotype similar to what has been noted in other viral
and bacterial models (Huster et al., 2004; Joshi et al., 2007; Kaech et al., 2003; Ku et al.,
2000; Pearce and Shen, 2007). The tetramer+ cells in the PECs were phenotypically
similar to what was seen in the spleen (data not shown). Antigen-specific cells also
showed higher expression of the IL-2/IL-15 receptor-$ (CD122) compared to tetramercells. Consistent with recent publications using Listeria monocytogenes infection (Huster
et al., 2004), expression of the IL-7R# was decreased on tetramer+ cells 7 days following
immunization when compared to naïve CD8+ T cells (Figure 8, shaded gray histogram).
IL-7R# was also downregulated on a small population of tetramer- CD8+ T cells, which
would include primarily naïve cells but also a small population of activated cells (data not
shown).
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To assess the phenotype of the memory cell population, later time-points were
also examined. Live parasites cannot be recovered from the PECs beyond 5 days after
immunization (CD Dupont, personal communication), and it is difficult to consistently
detect parasite DNA even as early as 10 days following immunization, so it is very
unlikely that viable parasites persist in immunized mice for extended periods of time. As
late as 75 days following immunization, the tetramer+ cells for the most part maintained
an effector-like KLRG1+CD62L- phenotype (Figure 8, bottom panel). Expression of the
high-affinity IL-7 receptor, which has been identified as a cytokine receptor expressed on
long-term memory cells (Huster et al., 2004), was also examined. A representative
example is shown in Figure 8, and analysis of the tetramer+ population revealed that a
proportion of OVA-specific cells expressed the IL-7R# (67.7 ± 2.9%, n = 7 combined
from 3 different experiments). Overall, these experiments demonstrated that antigenspecific cells at the site of infection as well as in secondary lymphoid tissues resembled
an effector population up to 75 days following immunization.
As data emerged from these studies, it became apparent that the kinetics of the
CD8+ T cell response to CPS-OVA differs from what has been reported for replicationsufficient strains of T. gondii. While the antigen-specific response induced by CPS-OVA
peaks approximately 10 days following immunization in both the spleen and PECs, work
from other groups has demonstrated that optimal CD8+ T cell responses induced by
replicating parasites are not detectable until 2 weeks following infection (Kwok et al.,
2003; Lutjen et al., 2006). To directly compare the development of antigen-specific
responses, mice were given the same dose of 105 CPS-OVA or Pru-OVA tachyzoites
intraperitoneally, and tetramer responses were assessed at two time-points. Pru-OVA and
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CPS-OVA (derived from an RH strain) are derived from different strains of T. gondii that
have previously been shown to differ in virulence to the host (Saeij et al., 2006). In this
comparison, CPS-OVA induced significantly higher frequencies of OVA-specific CD8+
T cells in the spleen (Figure 9A) as well as in the PECs (data not shown) 8 days
following infection. However, by day 14, the pattern had reversed such that Pru-OVA
responses were now significantly higher in the spleen with a trend towards higher
responses in the PECs, while CPS-OVA-induced CD8+ T cell responses had started to
contract (Figure 9B). However, work from our laboratory (Tait ED et al., submitted) has
compared replicating and non-replicating Type 1 strains and demonstrates that CPS-OVA
induces higher frequencies of antigen-specific CD8+ T cells compared to its replicationsufficient parental strain, RH-OVA. Nevertheless, both CPS-OVA and Pru-OVA
generate antigen-specific T cells with a similar effector-like phenotype at these time
points, and OVA-specific cells express low levels of CD62L and CD127, and high levels
of KLRG1 and CD122 (Figure 9C), as well as high levels of CD44 (data not shown).

3.4 OVA-specific CD8+ T cells are cytotoxic
In addition to production of cytokines, another important function of antigenspecific CD8+ T cells is the lysis of infected cells. Indeed, one week following
immunization, many tetramer+ splenocytes had upregulated expression of granzyme B,
consistent with possible cytolytic activity (Figure 10A). While a proportion of the total
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CD8+ T cell population had also upregulated granzyme B, this frequency was lower when
compared to the tetramer+ population (5.5±1.6% vs. 70.3±8%). Two weeks following
immunization, a decreased frequency (40.9±3.7%) of antigen-specific cells stained
positive for this cytolytic effector molecule directly ex vivo, compared to what was seen
at day 7. To directly assess the cytolytic ability of these cells, an in vivo CTL assay was
developed based on earlier work (Barber et al., 2003). Briefly, unpulsed or OVA-peptide
pulsed splenocytes from congenic CD45.1 mice were CFSE labeled, mixed at a 1:1 ratio,
and injected into immunized (CD45.2) mice (as outlined in Figure 5). When immunized
recipient mice were analyzed, loss of the OVA peptide-pulsed CFSEhi population
indicated that CPS-OVA induced robust cytolytic activity in CD8+ T cells. While
cytolytic activity could be detected as soon as 4 hours after target cell transfer in the
recipient spleens, maximum lysis was achieved after a 16-hour incubation of the target
cells in the recipient mice (Figure 10B-C). Multiple experiments were combined from
various time-points from 7 to 30 days following immunization and demonstrated a
correlation between the level of cytotoxic activity and the frequency of antigen-specific
cells present at the time of the CTL assay (Figure 10D).
To better understand the requirements for cytotoxic activity, WT and perforindeficient mice were immunized with a single dose of 105 CPS-OVA. Studies with L.
monocytogenes in perforin-deficient mice demonstrated that these animals generated
increased frequencies of antigen-specific CD8+ T cells (Badovinac et al., 2000), and this
was proposed to be due to decreased killing of DC leading to increased antigen exposure
following infection. Similar to what was seen in this model, perforin-/- mice immunized
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with CPS-OVA generated an increased frequency of tetramer+ cells (Figure 11A; p =
0.0004 by student’s t test). Despite this, perforin-/- mice demonstrated significantly lower
levels of cytolytic activity against peptide-pulsed target cells when analyzed either 4
(92.3±0.1% vs. 43.5±4.6%, p = 0.0005) or 16 (99.9±0.1% vs. 82.3±0.8%, p < 0.0001)
hours following target cell transfer (Figure 11B); however, there was still a large
perforin-independent component. In addition to granule-mediated cytotoxicity, CD8+ T
cells can also mediate cytolysis via Fas-FasL interactions. To examine the contribution of
Fas to the perforin-independent pathway of cytolysis, Fas KO peptide-pulsed target cells
were mixed with WT target cells and unpulsed cells and transferred into immunized
mice. WT and Fas KO target cells were killed equally well, indicating that the perforinindependent cytotoxic activity generated in response to immunization is likely not
mediated via the Fas-FasL pathway (Figure 11C). Because the kinetics of cytotoxicity
induced by another killing mechanism, TNF-#, are much slower than the activity of
perforin and granzyme (Ratner and Clark, 1993), it is unlikely that TNF-#-mediated
killing was important during these assays.

3.5 Depletion of CD4+ T cells abrogates effector CD8+ T cell responses to
CPS-OVA
Different models of infection have shown diverse requirements for CD4+ T cell
help in the generation of effector CD8+ T cells. In the primary response to herpes simplex
virus (Jennings et al., 1991) or Mycobacterium tuberculosis (Serbina et al., 2001), CD4+
T cell help is required for the generation of a CTL response. However, primary CD8+ T
cell responses to L. monocytogenes (Sun and Bevan, 2003) and lymphocytic
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choriomeningitis virus (LCMV) (Shedlock and Shen, 2003) are CD4+ T cell-independent.
Following infection with a replicating strain of T. gondii, CD4+ T cell help is not required
for the generation of CD8 effector responses (Lutjen et al., 2006). To address whether
CD4+ T cell help was required in the absence of parasite replication, mice were depleted
of CD4+ T cells one week prior to immunization with two doses of 0.5 mg anti-CD4
antibody. One week following immunization, CD4-depleted mice demonstrated a
decreased frequency as well as total number of OVA-specific CD8+ T cells (Figure 12AB). However, the OVA-specific T cells generated in the absence of CD4+ T cell help
were still capable of making IFN-" in response to OVA protein stimulation (2.07 ± 0.8
vs. 1.15 ± 0.36 ng/ml by ELISA, no significant difference). Expression of KLRG1 was
decreased on antigen-specific CD8+ T cells following CD4 depletion (Figure 12C; 76.3 ±
3.2% vs. 21.77 ± 4% for CD4-depleted mice, p=0.0004). Additionally, CD8+ effector T
cells generated without CD4+ T cell help were capable of killing peptide-pulsed target
cells as demonstrated by an in vivo CTL assay, though the rates of cytolysis were
decreased (data not shown). This decreased level of killing is most likely related to the
lower frequency of antigen-specific CTL at this time, and as shown in Figure 10D, there
is a positive correlation between frequency of tetramer+ cells and levels of cytolysis.
3.6 Discussion
The studies presented here build on the original report using the cps-II parasites
and establish that this replication-deficient strain induces a protective response that is
dependent on CD4+ and CD8+ T cells. We took advantage of a parasite expressing OVA,
which allowed us to carefully and precisely characterize the numbers and frequencies of
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these antigen-specific CD8+ T cells, and provided new information about phenotype and
cytolytic function of these cells. While these studies were in progress, the Yap laboratory
proposed that antigen-specific T cells induced by cps-II immunization are heterogeneous
and can be subdivided into four sub-populations based on their expression of KLRG1 and
CD62L (Wilson et al., 2008). FI is CD62LhighKLRG1-, FII is CD62LlowKLRG1-, FIII is
CD62LlowKLRG1+, and FIV is CD62LhighKLRG1+, with the FIII population being most
enriched for granzyme B+ IFN-"-producing effector cells. Our results using a model
antigen, where T. gondii-specific cells can be precisely identified using a tetramer,
suggest that tetramer+ cells are almost entirely CD62Llo and KLRG1+, or falling entirely
into Fraction III as defined by the Yap group. Interestingly, the kinetics of Fraction III
cells most closely resembled the expansion of the tetramer+ CD8+ T cell population we
observed using the CPS-OVA immunization model, and further work will be needed to
examine whether these sub-populations are truly parasite-specific, and if so, what factors
influence their development.
One concern with these studies was that the OVA-specific response might not
represent the T cell response to bona fide T. gondii antigens. However, recent work from
two laboratories has identified endogenous epitopes of T. gondii in B10.D2 and BALB/c
mice (Blanchard et al., 2008; Frickel et al., 2008). In both of those studies, these
immundominant antigens were part of secreted molecules and so are likely to be
presented in a similar fashion to the model antigen used here and by others (Dzierszinski
et al., 2007; Pepper et al., 2004), suggesting that the findings presented in this work will
be representative of the polyclonal response to T. gondii. The identification of
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endogenous CD8+ T cell epitopes in mice on the more commonly studied C57BL/6 strain
will be fortuitous and will aid further study into this area.
One of the strengths of this experimental system is the ability to identify longlived populations of parasite-specific cells. The pattern of expression of some activation
and memory markers differed from what has been seen in other models where the
duration of antigen exposure is limited, such as in a model of acute LCMV infection
(Kaech et al., 2003). In that system, for example, antigen-specific cells downregulate
expression of the IL-7R# quickly following activation, and one week after infection
nearly all antigen-specific cells are negative for IL-7R#. The functional consequences of
dynamic IL-7R# are relevant because studies in other systems have correlated the
expression of this marker with the capacity to form CD8+ T cell memory, and in LCMV
infection nearly 100% of cells regain expression of that marker by day 40 (Kaech et al.,
2003). This is in contrast with what was seen after CPS-OVA immunization, where only
approximately two-thirds (67.7 ± 2.9%) of OVA-specific splenocytes express high levels
of IL-7R# 75-90 days after immunization. However, recent reports on antigen-specific
CD8+ T cells in Trypanosoma cruzi-infected, drug-cured mice suggest that the conversion
of CD8+ T cells to a memory phenotype occurs very slowly (Bixby and Tarleton, 2008;
Bustamante et al., 2008). One implication of this analysis is that the combination of
markers commonly used to track memory populations may have to be tailored to
individual pathogens and may not be applicable to every infection.
The initial expectation was that a replicating form of T. gondii, that induces tissue
damage and produces increasing amounts of antigen, would promote a more rapid and
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quantitatively greater CD8+ T cell response than that generated by the CPS parasites.
Unexpectedly, these studies revealed that CPS-OVA induced an adaptive CD8+ T cell
response with faster kinetics than reported with replicating parasites (Kwok et al., 2003;
Lutjen et al., 2006). One potential explanation for this difference is that replicating
parasites produce factors that limit host cell proliferation and cytokine responses
(Candolfi et al., 1994; Khan et al., 1995). These effects would presumably be muted if the
parasite cannot replicate. Further studies will be needed to characterize early immune
responses to the non-replicating parasite, including how the innate and inflammatory
response contributes to the robust generation of the CD8+ T cell response following CPSOVA infection. While we did not directly measure IL-12 levels, there has been one report
that CPS parasites can induce high levels of IL-12p70 at the site of infection as well as
the spleen (Gigley et al., 2009), consistent with the idea that this cytokine is a major
determinant promoting CD8+ T cell responses during CPS-OVA infection. This idea will
be further addressed in Chapter 4.
Previous analysis of cytotoxic responses induced by T. gondii required that
splenocytes from infected mice or those immunized with STAg undergo expansion in the
presence of exogenous cytokines for 6-7 days, which may have influenced their effector
function (Hakim et al., 1991). In contrast, direct ex vivo staining 7 days following CPSOVA immunization showed that nearly 100% of OVA-specific cells expressed the
cytolytic effector molecule granzyme B, and an in vivo CTL assay confirmed that these
cells were cytolytic. While cytolytic activity was decreased in perforin-deficient mice,
these mice were still able to generate a robust antigen-specific CD8+ T cell response to
CPS-OVA and could mediate a degree perforin-independent cytolysis.
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As discussed earlier, the requirement for CD4+ T cell help in the generation of
CD8+ effector T cell responses can differ depending on the type of infection. In studies
with T. gondii, it was previously demonstrated that CD4 KO mice had decreased numbers
of antigen-specific CD8+ T cells as demonstrated by a precursor cytotoxic T lymphocyte
assay (Casciotti et al., 2002). This defect was only seen at late time points following T.
gondii infection, however it is possible that defects were also present earlier during
infection but were not detectable by the methods available at that time. In another model
of T. gondii infection, CD4+ T cell help was required to maintain antigen-specific CD8+ T
cells in the brain during chronic infection (Lutjen et al., 2006), but did not affect
generation of acute CTL responses. Studies with another type of protozoal infection,
Trypansoma cruzi, demonstrated that CD4+ T cell help was required during the primary
response to immundominant epitopes (Padilla et al., 2007). The findings presented here
might thus be influenced by the fact that the H-2Kb-restricted SIINFEKL epitope is
known to be immunodominant. While CD4+ T cell production of IL-2 has been regarded
as the most likely mechanism that contributes to the development of CD8+ T cell
responses, there may be an alternative explanation. One possibility is that CD4+ T cell
help is required to license dendritic cells to promote optimal CD8+ T cell effector and
memory responses, something that has been shown with HSV-1 infection (Smith et al.,
2004). Regardless, these results suggest that in a vaccine setting, both CD4+ and CD8+ T
cell epitopes should be targeted in order to drive a protective response.
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Chapter 4: c-Rel in the Generation of CD8+ T cell
Responses
4.1 Introduction
The NF-!B transcription factor c-Rel is exclusively expressed in immune cells
and plays a role in numerous cellular functions including proliferation, survival and
production of chemokines and cytokines. c-Rel has also been implicated in the regulation
of multiple genes that are involved in innate and adaptive immune responses to the
intracellular protozoan parasite T. gondii, in particular IL-12. Previous studies from this
laboratory have defined a critical role for c-Rel in resistance to T. gondii, though this
earlier work did not clarify whether CD8+ T cells had an intrinsic requirement for c-Rel,
or if this transcription factor was required for maintenance of CD8+ memory T cell
populations. To better understand how this transcription factor controls the CD8+ T cell
response to this parasite, WT and c-Rel-/- mice were challenged with a replicationdeficient strain of T. gondii that expresses the model antigen ovalbumin. This thesis
chapter will discuss my work looking at the primary CD8+ T cell responses as well as
memory responses, and the T cell-intrinsic versus -extrinsic responses for the
transcription factor c-Rel. These results indicate that in this infection model, the major
influence of c-Rel in generation of CD8+ T cell responses is through its regulation of the
inflammatory environment, rather than playing a substantial T cell-intrinsic role.
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4.2 c-Rel is required for optimal antigen-specific CD8+ T cell expansion and
resistance to secondary challenge
Because c-Rel-/- mice are susceptible to infection with replicating strains of T.
gondii (Mason et al., 2004a), a model was used in which a replication-deficient strain of
T. gondii induces protective immunity in WT mice, and this depends on CD8+ T cells at
the time of secondary challenge (Fox and Bzik, 2002; Jordan et al., 2009). Moreover, as
introduced in the previous chapter, since this vaccine strain expresses the model antigen
ovalbumin, the endogenous CD8+ T cell response to OVA can also be tracked using
MHC class I tetramers. To first assess whether c-Rel was required for the ability of CPSOVA to induce protective immunity, groups of WT and c-Rel-/- mice were immunized
with 105 CPS-OVA parasites and challenged with virulent RH-OVA 30 days later. Naive
WT and c-Rel-/- mice succumbed to infection between 8 and 9 days following infection
(Figure 13). WT mice that had been immunized were able to control this challenge. In
contrast, immunized c-Rel-/- mice did not survive, though there was a significant and
reproducible delay in time to death in comparison to challenged naïve c-Rel-/- mice
(Figure 13, p = 0.0014 by one-way ANOVA). At the time of death large numbers of free
parasites could be found in the peritoneal cavities of immunized and challenged c-Rel-/but not WT mice, and all naïve challenged mice regardless of genotype (data not shown).
In this model, protective immunity is primarily dependent on CD8+ T cells, thus
studies were performed to assess if the absence of c-Rel affected the generation of an
antigen-specific CD8+ T cell population. WT and c-Rel-/- mice were immunized with
CPS-OVA and the antigen-specific response was tracked using a tetramer reagent that
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recognizes T cell receptors specific for the immunodominant SIINFEKL epitope derived
from ovalbumin, in the context of MHC I H-2Kb. Consistent with the data in Chapter 3,
analysis of the primary response revealed that WT mice displayed a robust primary
expansion (Figure 14A). Also consistent with their increased susceptibility to
rechallenge, c-Rel-/- mice exhibited a decrease in frequency as well as number of OVAspecific CD8+ T cells at all time-points examined in the first 30 days of infection (Figure
14 and data not shown). The combined results from three experiments analyzed 8 days
following immunization demonstrated that both the frequencies (7.175% ± 0.76 vs 1.8%
± 0.35, p < 0.0001) as well as absolute numbers (3.76 x 105 ± 8.0 x 104 vs. 5.04 x 104 ±
1.76 x 104; p = 0.0006) of antigen-specific splenocytes were significantly reduced in cRel-/- mice compared to WT control mice (numbers shown in Figure 14B). Similar results
were seen at this time-point in the PECs as well as the blood (data not shown). Thus,
during the primary response to CPS-OVA immunization, c-Rel is required for the optimal
development of antigen-specific CD8+ T cells, and this correlates with insufficient
protection during secondary challenge.

4.3 c-Rel is not required for effector function but is required to upregulate
the activation marker KLRG1
Although the data shown in Figure 14 indicate that c-Rel influences the
magnitude of the CD8+ T cell response, studies were performed to determine if the
antigen-specific cells generated in the c-Rel-/- mice were functionally competent.
Peritoneal cells from immunized WT and c-Rel-/- mice taken 8 days post-immunization
were stimulated ex vivo with OVA peptide. As TCR stimulation leads to down-regulation
64

of tetramer binding (Drake et al., 2005; Kao et al., 2005), dual staining for cytokines and
OVA tetramer was not successful. However, in response to anti-CD3 (not shown) or
OVA peptide stimulation, both WT and c-Rel-/- cells were capable of making IFN-" and
TNF-#. This conclusion was drawn by comparing the frequency of cells that produced
IFN-" in response to OVA peptide stimulation ex vivo (Figure 15B) to the frequency of
tetramer+ cells (Figure 15A) in the tissues of individual mice (summarized in Figure
15C). Of the cells that were making IFN-" in response to OVA peptide, there was no
difference in the MFI (535 ± 21 vs. 491.7 ± 23, p = 0.3). Similar frequencies of cells that
made IFN-" could also produce TNF-# ex vivo (32.7 ± 5.4 vs. 32.6 ± 7.7; n = 3/ group
from one representative experiment, no significant difference), and the MFI of TNF-#
from double-producers did not differ between WT and c-Rel-/- mice (468.7 ± 2.9 vs. 472
± 4.2; n = 3/ group from one representative experiment, no significant difference).
Splenocytes and PECs were also stimulated with soluble T. gondii antigens (STAg), and
IFN-" production was measured by ELISA. Similarly, less IFN-" was found in
supernatants from c-Rel-/- mice as compared to WT mice (data not shown); however, this
is consistent with the reduced numbers of antigen-specific CD8+ T cells generated
following immunization. Moreover when an in vivo cytolysis assay using transferred
OVA peptide-pulsed target cells was used to determine if c-Rel-/- antigen-specific CD8+ T
cells could mediate cytotoxicity, no defect was observed in the ability of c-Rel-/- mice to
kill the transferred target cells (Figure 15D). However, as shown in Figure 9C (Chapter
3), maximum cytolytic activity is reached at 16 hours, when this assay was analyzed. If
these mice had been examined earlier it is likely the levels of cytolysis would have been
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lower, given the reduced frequency of tetramer+ cells in c-Rel-/- mice (7.6-fold for the
data shown in Figure 15D).
WT and c-Rel-/- splenocytes were next subjected to tetramer staining and
compared to CD8+ T cells from naïve WT mice (Figure 16A). Phenotypic
characterization of antigen-specific splenocytes revealed no observable differences
between tetramer populations of WT and c-Rel-/- mice in their expression of CD62L,
CD122 or Granzyme B. The only significant phenotypic difference at the day 8 time
point was the expression of KLRG1; though originally described as an NK cell activation
marker, it has since been shown that KLRG1 is upregulated on CD4+ and CD8+ T cells
following infection (Beyersdorf et al., 2001; Robbins et al., 2003). In various models of
infection and inflammation its expression has been linked directly to the ability of CD8+
T cells to respond to IL-12 (Joshi et al., 2007; Kaech et al., 2003; Wilson et al., 2008).
Significantly fewer tetramer+ cells from the spleen (86.6 ± 2.7 vs. 36.6 ± 5.6; p < 0.0001)
or PECs (Figure 16B, 75.9± 2.8 vs. 35.5 ± 5.7; p < 0.0001) of c-Rel-/- mice expressed
KLRG1, suggesting that the CD8+ T cells induced by CPS-OVA in c-Rel-/- mice are
either not able to respond to IL-12, or that they are not receiving enough of this cytokine.
Preliminary analysis of T-bet, a transcription factor linked to IL-12 production, did not
indicate any defect in c-Rel-/- tetramer+ cells (MFI of 399 versus 418 in one experiment),
though this should be analyzed more thoroughly in future experiments.
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4.4 A T-cell extrinsic function for c-Rel in the regulation of CD8+ T cell
responses
In parallel, studies using a replication competent strain of T. gondii expressing
OVA (Pru-OVA) were used to distinguish T cell-intrinsic versus T cell-extrinsic
requirements for c-Rel. c-Rel-/- mice were crossed with OTI transgenic mice to generate
TCR transgenic CD8+ T cells lacking c-Rel. WT and c-Rel-/- OTI cells were transferred
into Thy-disparate recipient mice that were infected one day later with Pru-OVA. When
T cell responses were analyzed between 7-9 days following infection, WT and c-Rel-/OTI cells expanded similarly in terms of frequency as well as number (Figure 17A-B).
This finding indicates that, in this system of infection-induced proliferation, CD8+ T cells
themselves do not intrinsically require c-Rel. It further suggests that other factors in the
c-Rel-/- environment, such as pro-inflammatory cytokines or CD4+ T cell help, might
contribute to the decreased generation of tetramer cells in c-Rel-/-mice. Another potential
explanation for the defective CD8+ T cell responses was a lack of CD4+ T cell help.
While adoptive transfer studies to see if CD4+ T cell help from WT mice could restore
CD8+ T cell effector responses in c-Rel-/- mice were not performed, it is likely that defects
in c-Rel-/- CD4+ T cells contributed to the poor CD8+ T cell responses, given what is
known about their reduced capacity to proliferate and to produce IL-2. The CD4+ T cell
depletion studies described in Chapter 3 did define a requirement for CD4+ T cell help
during the effector response to immunization, suggesting that CD4+ T cell help could be
one contributing factor in the sub-optimal CD8+ T cell expansion of c-Rel-/- mice.
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The WT host environment also impacted the phenotype of the transferred antigenspecific OTI cells, because the c-Rel-/- OTI cells were able to express similar levels of
KLRG1 compared to WT cells (Figure 18A). This suggests that the inability of cells to
express this marker in c-Rel-/- mice is not intrinsic to the T cell but is dependent on
accessory cells. This was further supported by reciprocal adoptive transfer experiments
where WT OTI cells were transferred into WT and c-Rel-/- recipients, and infected with
Pru-OVA. Donor cells were analyzed at day 8 and in this system WT OTI-GFP cells
demonstrated decreased expression of KLRG1 following adoptive transfer into a c-Rel-/recipient (Figure 18B). To further explore the defective environment, the ability to
produce cytokines ex vivo in response to OVA protein and OVA peptide was analyzed.
Figure 19 demonstrates that WT recipient APC (top) could support production of IFN-"
by these WT OTI-GFP T cells, while c-Rel-/- recipient APC (bottom) were defective
when T cells were stimulated with OVA protein (p = 0.02) even when IL-2 was added
(p= 0.02). The c-Rel-/- APC could only induce potent IFN-" production when the cells
were stimulated with OVA peptide (p = .n.s. for OVA peptide, even with IL-2). Together,
these studies clearly indicate that the c-Rel-/- environment does not provide an optimal
environment for the activation of WT CD8+ T cells.

4.5 IL-12 and regulation of CD8+ T cell responses
One possible candidate that may explain the defective CD8+ T cell responses in cRel-/- mice is IL-12. This cytokine is known to contribute to the primary expansion of
CD8+ T cells in response to infection with a number of organisms, serving as “signal 3”
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in addition to the obligatory TCR/MHC plus co-stimulation required to generate an
antigen-specific response (Pearce and Shen, 2007). Moreover, c-Rel-/- mice have been
reported to have defects in the acute production of IL-12 at the site of infection (Mason et
al., 2004a). Therefore, studies were performed to assess the role of IL-12 in the
development of antigen-specific CD8+ T cells in response to CPS-OVA. WT mice were
treated with 2 doses of anti-IL-12p40 antibody on day -1 and day 2 of infection with
CPS-OVA and this resulted in decreased generation of tetramer+ cells in the spleen (11.3
± 1.4% vs. 2.4 ± 0.3% (p = 0.0008); Figure 20A-B). IL-12 depletion also caused a
significant decrease in the expression of KLRG1 on tetramer+ cells in the spleen (82.5 ±
1.6% vs. 39.8 ± 6.9% (p = 0.0038); Figure 20C-D).
Because c-Rel-/- mice have previously been shown to exhibit defects in acute IL12 responses to T. gondii at the site of infection (Mason et al., 2004a), it was pertinent to
determine if this cytokine could restore the generation of the CD8+ T cell response.
Therefore, c-Rel-/- mice were treated i.p. with exogenous IL-12 to determine if this
cytokine was able to restore antigen-specific CD8+ T cell responses. In the PECs, this
treatment resulted in increased frequencies and numbers of OVA-specific CD8+ T cells
(Figure 21A, C). However, this treatment did not consistently restore CD8+ T cell
responses in the spleen (Figure 21B, D). We also determined that c-Rel-/- mice given IL12p70 at the time of immunization generated increased numbers and frequencies of
antigen-specific IFN-"-producing cells in the PECs (Figure 22A-B), while the number of
cytokine-producing cells was not consistently rescued in the spleens of IL-12-treated
mice (data not shown). We speculate that this partial rescue is due to inadequate levels of
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the cytokine reaching the spleen, while ample levels were present in the site of injection.
Alternatively, it is possible that another factor, such as failure of a required subset of cells
to migrate into spleen, could also be responsible for the lack of a normal CD8+ T cell
response in the spleen of c-Rel-/- mice. Regardless, in the CPS-OVA immunization
model, IL-12 dictates both the initial expansion, as well as the effector phenotype, of the
antigen-specific CD8+ T cell population.

4.6 c-Rel and the formation of memory CD8+ T cells
Attempts to clarify the role of c-Rel in the generation or maintenance of CD8+ T
cell memory have been limited, but the approach of using replication-deficient parasites
allowed for investigation of these responses at late time-points following infection. Thus,
various tissues of mice were examined 2-3 months following immunization, and this
analysis showed that not only were antigen-specific cells maintained in the spleen, but
unexpectedly, they were present at levels similar to the WT controls (Figure 23A-B).
Similar frequencies of tetramer-specific cells were also identified in the blood and bone
marrow, indicating that c-Rel-/- mice were able to maintain a pool of memory CD8+ T
cells following immunization. It was not clear that antigen-specific cells induced by CPSOVA would be able to survive, since c-Rel has been associated with upregulation of prosurvival family members. However when the expression of Bcl-2 was examined in WT
and c-Rel-/- tetramer+ splenocytes 35 days after immunization, there was no significant
difference in terms of percentage (52.9 ± 3.45 vs. 52.6 ± 0.9) or MFI (318 ± 1.5 vs. 334.5
± 3.5).
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Although the frequency of memory CD8+ T cells was comparable in WT and cRel-/- mice, additional studies were performed to compare their phenotype. At the timepoints examined, up to 3 months post-immunization, antigen-specific CD8+ T cells in
both WT and c-Rel-/- mice were primarily KLRG1high and CD62Llow, therefore
resembling effector cells. KLRG1, which was significantly lower on c-Rel-/- tetramer
cells at acute time-points, was now expressed at a similar frequency on OVA-specific
cells (data not shown). CD27, a member of the TNF receptor superfamily previously
demonstrated to be expressed more highly on memory CD8+ T cells, was expressed more
highly on c-Rel-/- as compared to WT tetramer+ cells (MFI 491 ± 9 vs. 589 ± 4.7; p =
0.0006). A significant difference was also noted in the expression of CD127, the IL-7R#,
which was also higher on c-Rel-/- tetramer+ cells both in terms of frequency of IL-7R#
cells (Figure 23C; 67.7 ± 2.9 vs. 88.5 ± 0.8, p<0.0001) as well as MFI (236 ± 10.5 vs.
305 ± 15; p = 0.0028).
Another capacity correlated with memory CD8+ T cell function is their ability to
expand more rapidly compared to naïve CD8+ T cells following pathogen exposure
(Kaech et al., 2002). Because immunized c-Rel-/- mice were not able to survive
rechallenge with RH-OVA, another approach was taken to assess the memory responses
of antigen-specific CD8+ T cells. WT and c-Rel-/- mice were immunized with 105 CPSOVA parasites, and 30 days later naïve and immune mice were challenged with a ten-fold
higher dose of CPS-OVA (106). 5 days following challenge, the expansion and function
of the antigen-specific CD8+ T cell response was analyzed. As expected, there was an
expansion of tetramer-specific cells in WT mice following challenge (Figure 24).
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However, despite the requirement for c-Rel in the induction of the primary CD8+ T cell
response, OVA-specific cells from the PECs or spleen of c-Rel-/- mice expanded to a
much greater degree. Closer examination revealed that the increase in frequency of
tetramer+ cells was significantly higher in the PECs (p = 0.001) as well as the spleen (p =
0.29) of challenged c-Rel-/- mice compared to the challenged WT mice, when each group
was compared to mice that had been immunized 30 days prior (Figure 24A, C). Similarly,
the increase in number of tetramer+ cells was significantly higher in the spleen (p = 0.01)
as well as the PECs (p = 0.0008) of challenged c-Rel-/- mice, compared to challenged WT
mice (Figure 24B, D). These results were confirmed in experiments in which T cells were
isolated from immunized WT and c-Rel-/- mice, and transferred to naïve mice that were
then challenged with 106 CPS- OVA. Analysis of the tetramer-specific population
revealed that c-Rel-/- CD8+ T cells maintained their enhanced ability to proliferate
following rechallenge (Figure 25A-B), with larger differences noted in the PECs (fold
increase of 37.4 ± 3.7 for WT vs. 63.4 ± 2.3, p = 0.0004) as compared to the spleen (fold
increase of 12.45 ± 0.9 for WT vs. 14.83 ± 2, p = n.s.).
Despite this ability to greatly expand the CD8+ T cell population, c-Rel-/- mice
were unable to survive secondary lethal challenge, as shown in Figure 13. Therefore
experiments were performed to assess whether the effector function of c-Rel-/- memory
CD8+ T cells was altered. As shown in Figure 26, while cells from immune or challenged
WT mice produced IFN-" in response to most of the stimuli, splenocytes from c-Rel-/mice had an impaired ability to produce IFN-" following stimulation with OVA protein,
STAG, or anti-CD3, and in fact made very low levels of cytokine in response to OVA
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peptide (Figure 26A). In contrast, when immune c-Rel-/- T cells were adoptively
transferred in WT mice and then rechallenged with CPS-OVA, the WT environment
restored their ability to make IFN-" (Figure 26B). Thus, one potential explanation for the
inability of c-Rel-/- mice to survive lethal rechallenge is their inability to produce
sufficient levels of cytokines to protein antigens. One caveat of this adoptive transfer setup is that the challenge dose of CPS-OVA utilized in this experiment induced an
endogenous host response easily identified by tetramer staining; thus, the ELISA
responses could be attributed at least in part to the host response. A more thorough
analysis of donor cell cytokine production would be needed to confirm that the c-Rel-/CD8+ T cell responses were effectively rescued by the WT host environment, and in the
future this could be assessed ex vivo by flow cytometry to examine donor-specific
cytokine responses.

4.7 Conclusions
Previous studies demonstrated the importance of the transcription factor c-Rel in
the development of a potent Th1 immune response to the parasite T. gondii and have also
implicated c-Rel in the development of T cell responses in a variety of other settings
(Campbell et al., 2000; Hilliard et al., 2002; Mason et al., 2004b; Wang et al., 2008). In
contrast, another report has indicated that c-Rel was not required for the activation and
effector function of CD8+ T cells in the context of influenza infection (Harling-McNabb
et al., 1999). Attempts to assess the role of c-Rel in the generation of CD8+ T cell
responses to toxoplasmosis have been hindered by the susceptibility of c-Rel-/- mice to
this organism. This difficulty was overcome by utilizing a non-replicating strain of T.
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gondii engineered to secrete the model antigen OVA, thus allowing the primary and
secondary antigen specific CD8+ T cell response to be tracked with improved specificity
(Jordan et al., 2009). Unexpectedly, use of this experimental system revealed that while
c-Rel is required for optimal generation of CD8+ T cells in response to T. gondii, it is not
intrinsically needed by CD8+ T cells for their expansion or effector function.
There are several possible explanations for the role of c-Rel in the development of
an optimal primary CD8+ T cell response. IL-12 is essential for protective CD8+ T cell
responses to T. gondii and previous studies have identified a key role for c-Rel in the
production of IL-12 (Wilson et al., 2008). Although there are also c-Rel-independent
pathways for IL-12 production (Mason et al., 2002) there is a defect in early IL-12 in cRel-/- mice infected with T. gondii (Mason et al., 2004a). Moreover, studies by
Gerondakis and colleagues highlighted a role for c-Rel in regulating the differentiation
and survival programs of plasmacytoid dendritic cells (O'Keeffe et al., 2005), which are
an important source of IL-12 during toxoplasmosis. Additionally, recent work has
associated the expression of KLRG1 by CD8+ T cells with exposure to IL-12 (Wilson et
al., 2008), and while antigen-specific CD8+ T cells from c-Rel-/- mice were for the most
part phenotypically similar to WT antigen-specific CD8+ T cells, the only major
difference was reduced expression of KLRG1. In addition to regulating the effector
phenotype of CD8+ T cells, IL-12 also impacts the initial proliferation of these cells,
which likely explains the impaired expansion of CD8+ T cells in c-Rel-/- mice. Indeed,
providing exogenous IL-12 to c-Rel-/- mice resulted in a partial rescue of CD8+ effector T
cell expansion following immunization.
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The observation that OVA-specific CD8+ T cells could expand normally when
transferred to WT recipients and challenged further supports the idea that c-Rel is playing
a CD8+ T cell-extrinsic role during T. gondii. For example, several groups have reported
reduced ability of c-Rel-/- CD4+ T cells to produce IL-2, and the ability of the CPS-OVA
parasites to promote CD8+ T cell responses is dependent on CD4+ T cells. Thus, defects
in the CD4+ T cell compartment, in terms of numbers or in terms of functionality, would
also impact the CD8+ T cell response. Indeed, while the ability of c-Rel-/- OTI cells
transferred into WT mice to expand normally indicates that c-Rel is not intrinsically
required for optimal CD8+ T cell responses, these experiments do not distinguish between
the role of c-Rel in antigen-presenting cell populations and CD4+ T cell help.
Perhaps the most surprising element of these studies was that although c-Rel-/mice failed to survive a secondary challenge with virulent T. gondii, there were
comparable levels of memory CD8+ T cells in the WT and c-Rel-/- mice. Further, upon
rechallenge c-Rel-/- mice exhibited increased expansion of the CD8+ T cell subset
compared to WT mice. This phenotype may also be a function of reduced production of
IL-12 as several studies indicate that although IL-12 is important for CD8+ effector T cell
generation and function, its absence allows CD8+ T cells to form better memory (Joshi et
al., 2007; Pearce and Shen, 2007). This conclusion seems to depend on the system used,
as IL-12 has not been shown to induce similar effects in all infection models. IL-12 also
seems to be important in the expansion of effector CD8+ T cells in response to L.
monocytogenes and T. gondii (Pearce and Shen, 2007; Wilson et al., 2008). However, IL12 is not as critical in some viral systems including LCMV and VSV, while there are
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contradictory reports about its role in CD8+ T cell responses against vaccinia virus
(Keppler et al., 2009; Thompson et al., 2006).
Several viral and bacterial systems have been used extensively to define the
factors that influence the development of CD8+ T cell effector and memory populations.
Perhaps not surprisingly, in other infectious settings, there are some differences
emerging; for instance the acquisition of a CD62L+ memory phenotype seems to take
longer in parasite infection as compared to LCMV (Bustamante et al., 2008; Wherry and
Ahmed, 2004). Certainly, much work remains to be done in the study of memory CD8+ T
cells that develop in distinct inflammatory environments and the contributions made by
different cytokines, including IL-12. However, our results are in agreement with a model
supporting a role for IL-12 in the promotion of primary responses while its absence
enhances development of memory CD8+ T cells, and this will be further discussed in
Chapter 5. Determining the factors that regulate CD8+ T cell effector and memory
development has strong implications for rational vaccine design, or control of immune
system dysfunction. Overall, it seems likely that c-Rel is not required for the function of
mature CD8+ T cells. This is in agreement with previous work that showed relatively
normal function and proliferation of effector CD8+ T cells induced following infection of
c-Rel-/- mice with influenza and HSV (Harling-McNabb et al., 1999; Mintern et al.,
2002). Rather, the work presented here suggests that c-Rel plays a significant role in
creating the inflammatory environment that influences the development and function of
the CD8+ T cell response and memory formation.
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Chapter 5: Discussion and Future Directions
5.1 Introduction
As introduced earlier in this thesis, T. gondii is a parasite of major human and
veterinary importance. It has also provided an excellent model to help define many of the
general principles that define resistance to other parasitic infections, and provided
insights into the innate mechanisms of resistance to intracellular organisms and how
adaptive immunity functions during chronic infection. While a number of immune cell
subsets contribute to resistance against this pathogen, CD8+ T cells that produce the
cytokine IFN-" are a critical component of the immune response against T. gondii, and
are the focus of this thesis. While the protective capacity of this immune cell subset had
been known for some time, gaps in knowledge remained, particularly as related to the
factors that contribute to the generation of protective CD8+ T cell responses. The
beginning stages of this thesis were dedicated to understanding the cellular immune
response to immunization, utilizing a strain of the parasite that was unable to replicate in
mice. These parasites allowed us to study memory responses even in mice that are
normally susceptible to acute infection. This work revealed a requirement for CD4+ T cell
help in the CD8+ T cell effector response to immunization. The latter part of this thesis
focused on using this model to understand how one transcription factor from the NF-!B
family, c-Rel, could influence CD8+ T cell responses to T. gondii. These studies showed
that despite being implicated in T cell proliferation and survival, c-Rel was not
intrinsically required for CD8+ T cell expansion in response to T. gondii, nor was it
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required for secondary expansion. Rather, the sub-optimal inflammatory environment,
associated with reduced production of IL-12, contributed to shaping the size and
phenotype of the CD8+ T cell response. The importance and context of these findings will
now be discussed.

5.2 The inflammatory environment
It has long been appreciated that the environment in which T cells are generated
contributes to their activation and effector function; for example, different pathogens are
known to induce a diverse set of outcomes, causing CD4+ T cells to differentiate either
into Th1 or Th2 cells, characterized by different patterns of cytokine production (Murphy
and Reiner, 2002). The inflammatory environment, including infected or activated
antigen-presenting cells and cytokines and chemokines they produce, contributes to this
differentiation process of CD4+ T cells (Murphy et al., 2000). More recently, a more
nuanced approach has made clear that the inflammatory environment can also contribute
to the differentiation of CD8+ T cells by impacting either the size or the phenotype of the
population through, for example, IL-12 or Type I interferons (Joshi et al., 2007; Pearce
and Shen, 2007; Thompson et al., 2006). During T. gondii infection, as for many
organisms, differences in inflammation will be a function of multiple variables including
type and dose of infection, parasite virulence factors, and numerous host factors.
The contribution of the inflammatory environment to CD8+ T cell development
during T. gondii infection is complex because there are three major clonal strains of this
parasite that possess disparate abilities to replicate, disseminate and cause disease in vivo.
Virulent strains of T. gondii demonstrate widespread parasite dissemination and tissue
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destruction, resulting in systemically high levels of IL-12 and IFN-" that have been
linked to host pathology (Gavrilescu and Denkers, 2001). Virulence factors have recently
been identified and differ between strains, because expression of specific rhoptry proteins
from Type I strains could render Type II or Type III strains of T. gondii pathogenic to
mice (Saeij et al., 2006; Taylor et al., 2006). All of these strains induce a lytic infection,
and this parasite destruction of tissues upon host cell egress also contributes to the
inflammatory environment (Black and Boothroyd, 2000).
It has been known for some time that T. gondii can dampen the pro-inflammatory
response through interference with multiple intracellular signaling pathways (Denkers,
2003). For instance, several groups have found that T. gondii interferes with NF-!B at the
level of subunit phosphorylation (Shapira et al., 2002) and nuclear translocation of this
transcription factor (Butcher and Denkers, 2002; Butcher et al., 2001). T. gondii also
induces the anti-inflammatory cytokine IL-10, which through its direct inhibition of IL12 can dampen developing immune responses against the parasite (Butcher et al., 2005b;
Khan et al., 1995). Additionally, some work has suggested that more virulent strains of T.
gondii have enhanced migration, which could contribute to dissemination and virulence
(Barragan and Sibley, 2002). Thus, the complicated life cycle of T. gondii impacts the
inflammatory environment in infected hosts by expressing virulence factors, or by
directly inhibiting host immune responses.
In other models of infectious disease, antigen burden is another factor that
influences the developing CD8+ T cell response. For instance, during L. monocytogenes
infection, using antibiotic treatment to limit antigen exposure regulates the size of the
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CD8+ effector T cell pool in some studies (Mercado et al., 2000) but not others (Williams
and Bevan, 2004). To limit the number of variables that would affect CD8+ T cell
development, I took advantage of CPS-OVA parasites that provided a system of limited
antigen exposure and host cell cytolysis. Though CPS-OVA was derived from a Type I
strain, I would expect limited production of any virulence factors produced after
immunization due to the lack of parasite replication and subsequent parasite
dissemination. The availability of different strains that expressed OVA allowed the
comparison of immune responses that developed in environments with varying levels of
inflammation. I found that 8 days following infection, the frequency of OVA-specific
cells in the CD8+ T cell population inversely correlated with the amount of inflammation.
Thus, the replication-deficient CPS-OVA parasites induced the highest levels of antigenspecific CD8+ T cells, followed by the Pru-OVA Type II strain parasites (Chapter 3),
while the highly virulent RH-OVA Type I strain generated barely detectable levels of
OVA-specific CD8+ T cells (Tait et al., 2010).
The studies presented in this thesis and demonstrated by Tait and colleagues also
correlated the induction of a T. gondii-specific CD8+ T cell population in response to PruOVA or RH-OVA with the proliferation or recruitment of CD11c+ and myeloid DC
populations to the site of infection. However, while a CD11b+CD8- DC population did
expand following Pru-OVA infection, the DC populations seen in the PECs following
CPS-OVA closely resembled those from naïve mice (Figure 27A). Additionally, while
Pru-OVA induced upregulation of MHC Class II, CD80 and CD86, the phenotype of
DCs identified during CPS-OVA more closely resembled naïve mice (Figure 27B and
data not shown).
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Thus, the presence of expanded and activated DC populations, at least at the time points
we examined, was not required for CPS-OVA parasites to induce a potent CD8+ T cell
response (as demonstrated in Chapter 3.3). Because we found no differences in DC
populations that might explain the ability of CPS-OVA to induce this robust OVAspecific CD8+ T cell population, I next wanted to examine more specific factors known to
contribute to effector cell generation during T. gondii infection.
Numerous studies have examined the importance of dendritic cell production of
IL-12 and priming of CD8+ T cell responses during T. gondii, and the depletion as well as
rescue experiments discussed earlier in this thesis clearly demonstrate a role for this
cytokine during infection with CPS-OVA. While other groups have reported that CPS
parasites induce high systemic levels of IL-12p70 (Gigley et al., 2009), we have been
unable to confirm their findings. Thus, despite the observation that CPS parasites induce
no overt inflammation, do not disseminate widely, and cannot cause cytolysis of host
cells, they do generate protective responses to rechallenge. Further, the generation of an
OVA-specific CD8+ T cell response to immunization was dependent on IL-12 and CD4+
T cell help. While previous work in other infections suggests a model where the ability of
a pathogen to generate a robust CD8+ T cell depends on the degree of inflammation and
the amount of antigen exposure, the CPS-OVA experiments presented here suggest that
“more” might not always equal “better” in terms of the generation of protective CD8+ T
cell responses.
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5.3

Antigen presentation
Naïve CD8+ T cells are activated by professional antigen-presenting cells that

present the correct peptide in the context of MHC Class I on their cell surface. It was
previously believed that only cell-associated endogenous antigens were presented by
MHC Class I molecules, consistent with models in which CD8+ T cells can only
recognized virally-infected cells or cancer cells. More recently, it has been appreciated
that during transplant rejection, or during infections that target parenchymal cells,
professional APC can sample and display exogenously-derived proteins on MHC I in the
process of cross-presentation (Rock and Shen, 2005). A model of transient dendritic cell
(DC) depletion was important in clarifying that this pathway of cross-priming was
critically required for generation of antigen-specific CD8+ T cells in mice infected with L.
monocytogenes or P. yoelii (Jung et al., 2002; Liu et al., 2006). However, it must be
noted that there is evidence in favor (John et al., 2009), as well as evidence against
(Dzierszinski et al., 2007; Goldszmid et al., 2009; Gubbels et al., 2005), crosspresentation of antigen to CD8+ T cells during toxoplasmosis. Distinguishing which
pathways are involved in these events may not just be of academic interest as they impact
the type of pathogen antigens that are presented and may likely influence generation
vaccine-induced adaptive immunity. As will be discussed in the next section, model
antigen systems have been a key component to deciphering the pathways of antigen
presentation during parasite infection.
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5.3.1 Model antigen systems

At the time these thesis studies were initiated, the lack of defined endogenous T.
gondii CD8+ T cell epitopes meant that the ability to study antigen-specific T cell
responses was restricted. Similar issues have been encountered in many infectious
systems and with the advent of TCR transgenic mice, one strategy that has been
employed is the use of model antigens (Bertholet et al., 2006; Garg et al., 1997; Guzman
et al., 1998; Pan et al., 1995). Accordingly, a Type II strain of T. gondii expressing the
model antigen $-galactosidase was engineered and the response to this surrogate
microbial antigen was used to examine the immune response (Kwok et al., 2003; Lutjen
et al., 2006). A similar approach was initiated in the Hunter laboratory utilizing the model
antigen ovalbumin (Pepper et al., 2004). One strength of the OVA model system is the
extensive set of tools that has been generated: TCR transgenic mice, tetramers to track
antigen-specific cell populations, and a T cell hybridoma useful for studying antigen
presentation.
One caveat is that use of these transgenic systems may not accurately reflect what
occurs during a polyclonal response, and until similar experiments can be conducted
using endogenous T. gondii antigens these findings must be interpreted with care.
Nevertheless, recent work has described two T. gondii endogenous CD8+ T cell epitopes
in BALB/c mice, one derived from the dense granule protein GRA4, and the other from
the rhoptry protein ROP7 (Frickel et al., 2008). The Shastri laboratory identified an
immunodominant CD8+ T cell epitope derived from GRA6, another secreted protein
(Blanchard et al., 2008). As was demonstrated earlier with parasites that expressed model
antigens, the endogenous epitopes were located in secreted but not cytosolic proteins,
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serving as a confirmation of our model antigen approach. However, the fact that only
three endogenous epitopes have been identified from the many thousands of T. gondii
genes illustrates some of the difficulties associated with antigen presentation and epitope
discovery in parasites. One caveat is that the model antigens expressed by our transgenic
parasites might be secreted at higher levels than the endogenous proteins identified by
Frickel and colleagues, and experiments are underway to determine the amount of
ovalbumin that is secreted by different strains of T. gondii. Differences in amount of
protein secreted could explain why the levels of antigen-specific cells we identify by
tetramer staining during Pru-OVA or CPS-OVA infection are higher than what has been
seen with these endogenous epitopes (Blanchard et al., 2008; Frickel et al., 2008).
These model antigen systems have also helped to clarify how antigen presentation
occurs during T. gondii. Earlier work from the Roos and Hunter laboratories has provided
two different perspectives on whether or not only infected cells are able to present
antigen (Dzierszinski et al., 2007; John et al., 2009). It is likely that antigen presentation
pathways differ between Pru-OVA and CPS-OVA. As already mentioned, CPS-OVA
induces an immune response without host cell lysis, thus indicating that direct
presentation of antigen by infected cells is sufficient for priming of CD8+ T cell
responses during CPS-OVA. The use of two-photon microscopy to visualize the
interactions between antigen-specific T cells and DC during the priming phase is already
yielding critical insight into successful T cell priming, and this technique has already
been used by the Hunter laboratory and others to examine the behavior of different cell
populations during infection (John et al., 2009; Peters et al., 2008; Schaeffer et al., 2009;
Tarun et al., 2006; Wilson et al., 2009). However, this comparison is technically
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challenging, not least because of caveats due to using large numbers of adoptively
transferred cells, because the transfer of high numbers of TCR transgenic cells can alter
the kinetics, expansion, and phenotype of the immune response (Badovinac et al., 2007;
Badovinac and Harty, 2007). Despite this fact, two-photon microscopy promises to reveal
new insights into innate responses to infection and the interactions between different cell
populations in vivo.

5.4 c-Rel in Antigen Presentation
The use of model antigens as described above provided advantageous tools for
studying antigen presentation, since defined Class I- and Class-II restricted epitopes
within the OVA protein induce an endogenous T cell response. While IL-12 levels did
enhance the size of the effector CD8+ T cell population, another potential influence on T
cell expansion could be that c-Rel is required for optimal antigen presentation. In a model
of influenza infection, c-Rel-/- mice were able to mount a CTL response and had a small
delay in viral clearance, but this group did not determine if the flu-specific CD8+ T cell
population itself was reduced or less functional than WT mice (Harling-McNabb et al.,
1999). Another group found that c-Rel was not required for DC maturation or expression
of CD86 following LPS stimulation but that c-Rel-/- DCs were defective at inducing
allogeneic T cell stimulation (Boffa et al., 2003). Additionally, c-Rel was previously
shown to be required for the generation of CD8+ T cell responses in a model of
immunization dependent on cross-presentation, while it was not required to induce CD8+
T cell responses to herpes simplex virus (Mintern et al., 2002). Because IL-12 could
rescue the antigen-specific CD8+ T cell population in c-Rel-/- mice, this implies there was
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no impairment in antigen processing and presentation, though this needs to be studied
more in-depth.
An additional implication would be that either that c-Rel is not required for crosspresentation in the CPS-OVA model, or that this model does not require cross-priming to
induce a CD8+ T cell response. My work showed that CD8+ T cells from c-Rel-/- mice
had impaired cytokine responses to OVA protein but could respond similarly to WT cells
when stimulated with OVA peptide, suggesting that there were issues with antigen
processing or presentation in c-Rel-/- mice. Additionally, adoptive transfer experiments
revealed that WT OTI-GFP cells had defective cytokine responses against OVA protein
but not OVA peptide when transferred into c-Rel-/- mice, suggesting a defect in DC
antigen presentation or processing. It would be interesting to look more closely at
different components of antigen processing pathways in APCs because it is not known
whether or not c-Rel directly targets any of these genes.
To further address the issue of antigen presentation, splenic CD11c+ dendritic
cells were sorted from infected WT and c-Rel-/- mice to see if they could present antigen
in vitro to the B3Z cell line, a T cell hybridoma specific for ovalbumin. In these
experiments I found no defect in the ability of c-Rel-/- splenic dendritic cells to activate
B3Z cells, whether exogenous antigen was added or not, and if anything the c-Rel-/- DC
induced more activation of the B3Z cells (WT OD 0.159 vs. c-Rel OD 0.221 for 105 DC
without exogenous antigen; WT OD 1.48 vs. c-Rel OD 1.68 for 105 DC with exogenous
OVA peptide). However, this cell line is known to have lower thresholds for activation or
cytokine production as compared to naïve CD8+ T cells and thus the ability of c-Rel-/- DC
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to activate naïve T cells during T. gondii may be impaired. Related to this point, previous
work from the Hunter laboratory has implicated one subset of DC, the plasmacytoid DC
(pDC), in priming CD4+ T cell responses to T. gondii (Pepper et al., 2008). Whether this
subset contributes to CD8+ T cell priming is unclear. Previous reports have demonstrated
a two-fold reduction in the pDC population in c-Rel-/- mice, and demonstrated diminished
IL-12 production by pDC in response to TLR9 stimulation (O'Keeffe et al., 2005).
Therefore, it remains a possibility that defects in this population could contribute to the
diminished CD8+ T cell responses in c-Rel-/- mice though this needs to be examined in
more detail.

5.5 c-Rel in T cells
This thesis work aimed not only at deciphering CD8+ T cell responses to T.
gondii, but was also concerned with the role played by the NF-!B transcription factor cRel. As c-Rel has previously been described as playing a critical role in T cell
proliferation and cytokine production (Gerondakis et al., 1996; Liou et al., 1999), the
initial hypothesis at the start of these studies was that c-Rel would be intrinsically
required within the CD8+ T cell population for their expansion, activation and effector
function within the context of T. gondii infection. During LCMV infection, priming of
CD8+ T cells is dependent on Type I interferons (Thompson et al., 2006), however c-Rel
is not required for upregulation of virus-induced Type I interferons (Wang et al., 2007),
suggesting c-Rel-/- mice might experience different outcomes in terms of CD8+ T cell
responses depending on the inflammatory environment. Surprisingly, the data presented
here demonstrated that c-Rel is not intrinsically required for the effector response of
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CD8+ T cells to CPS-OVA, and that in the absence of c-Rel secondary responses were
enhanced. While c-Rel does not seem to be playing a T cell-intrinsic role in the CPSOVA model system, it is clearly contributing to the generation of T cell responses
through its role in APC and pro-inflammatory cytokines.
Indeed, one role that has been ascribed to c-Rel is that it functions to link innate
and adaptive immunity, by making naïve but not effector T cells that receive proinflammatory cytokine signals more receptive to TCR triggering (Banerjee et al., 2005).
As introduced earlier, study of individual NF-!B family members is complicated by the
fact that they may serve overlapping roles in certain situations. This might be why it has
been suggested that c-Rel modulates, but is not essential for, gene expression related to T
cell activation (Bunting et al., 2007). This might differ depending on whether they are
naïve, effector or memory CD8+ T cells, because while naïve T cells are highly
dependent on TCR signaling, memory cells can respond to cytokine signals alone, which
would act through distinct signaling intermediates. It is also possible that c-Rel interacts
with distinct molecules in CD8+ T cells compared to other cell populations. For instance,
c-Rel has been implicated as a key mediator of PKC-'-mediated survival signals
downstream of anti-CD3/anti-CD28 stimulation in CD8+ but not CD4+ T cells in vitro
(Saibil et al., 2007).
Another potential explanation for the enhanced secondary expansion of c-Rel-/CD8+ T cells following challenge is the absence of thymically-derived regulatory T cells
that has recently been demonstrated in c-Rel-/- mice (Isomura et al., 2009; Long et al.,
2009; Ruan et al., 2009). Regulatory T cells are known to be an important factor
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regulating the expansion of memory CD8+ T cells (Kursar et al., 2002; Suvas et al.,
2003), and at first we thought the absence of regulatory T cells might explain why the
challenged c-Rel-/- mice had such a large expansion of OVA-specific CD8+ T cells
compared to the WT mice. However, the finding in Figure 24 indicates this might not be
the case, because c-Rel-/- OVA-specific CD8+ T cells adoptively transferred into WT
hosts (that had normal numbers of T-regs) still expanded more than the WT memory cells
following secondary challenge. The influence of regulatory T cells in this system could
be more formally tested, for example by adoptive transfer of WT purified regulatory T
cells into immune c-Rel-/- mice prior to secondary challenge. In any case, this would not
fully explain the phenotype, because the c-Rel-/- OVA-specific cells were still able to
expand more robustly than WT cells after adoptive transfer in WT recipients. One other
possibility that we have considered is that c-Rel might be playing a negative regulatory
role in the proliferation of memory CD8+ T cells. This is, of course, completely
contradictory to its role as previously described in many different models of infection.
However, there is a precedent for NF-!B family members serving as negative regulators,
because p50-/- natural killer (NK) cells proliferate better than WT NK cells, potentially
via increased STAT5 activation (Tato et al., 2006). Further, other work has shown that
p50 homodimers can act as inhibitors of gene expression to suppress the immune
response (Carmody et al., 2007b; Zhong et al., 2002).

5.6 Memory during parasite infection
CD8+ T cell memory has been studied extensively in a number of infectious
models, and can be defined as the ability of antigen-specific cells to survive and provide
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protective immunity long-term (Rocha and Tanchot, 2006). In recent years the LCMV
system has provided a powerful experimental tool infection with a well-described
primary infection that has been used to define CD8+ T cell memory, with a peak in the
viral load around day 3 and clearance of virus from the tissues by around day 8
(Harrington et al., 2000; Wherry et al., 2003). This, along with earlier work looking at
human T cells (Sallusto et al., 1999), has lead to a model whereby 2 distinct subsets of
memory CD8+ T cells, central vs. effector, can be defined based on their anatomical
location, cell surface molecules, and effector functions (Wherry and Ahmed, 2004;
Wherry et al., 2003). How these subsets of cells arise is still a subject of some
controversy (Chang et al., 2007). At the time that this thesis was initiated, little was
known about CD8+ T cell memory development during parasitic infection, and how that
compared to what has been studied in viral systems.
It has been known for many years that T cells from chronically infected mice
confer protection upon adoptive transfer (Parker et al., 1991) or virulent challenge
(Gazzinelli et al., 1991), but the phenotype and function of the cells mediating this
protection had not been closely studied. Previous examination of the memory responses
induced by ts-4 were complicated by the fact that this strain can continue to replicate and
cause disease in immunodeficient hosts (Sayles and Johnson, 1996). The CPS-OVA
parasites enabled study of the antigen-specific cells and while OVA-specific cells were
easily detectable in the blood, bone marrow or spleen, they were difficult to detect in the
LN. For the most part, these OVA-specific CD8+ T cells still resembled effector memory
cells (KLRG1+CD62L-), even 3 months following immunization. I did see that a small
proportion (10-20%) of OVA-specific cells had high levels of CD62L and low levels of
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KLRG1, a phenotype typically associated with central memory T cells, though
approximately two-thirds were expressing high levels of IL-7R# (Chapter 3). Further
studies are required to determine whether or not these cells had functional differences
compared to CD8+ T cells with a similar phenotype that were generated in response to
viral or bacterial challenge.
As discussed previously, numerous studies have indicated that the proinflammatory cytokine IL-12 plays a key role in the response to T. gondii (Gazzinelli et
al., 1993; Gazzinelli et al., 1994; Hunter et al., 1995b; Khan et al., 1994). Evidence
continues to mount that this cytokine is also integral in the regulation of CD8+ T cell
memory and effector differentiation, with high levels of IL-12 correlated with the
preferential formation of effector cells but a poor memory pool (Joshi et al., 2007; Wilson
et al., 2008). While my work very clearly implicates IL-12 in the initial expansion of
parasite-specific CD8+ T cells, there was only correlative evidence that IL-12 levels
influenced memory generation to CPS-OVA. This evidence rests largely on two findings.
First, the observation that c-Rel-/- OVA-specific CD8+ T cells expressed higher levels of
CD127 and CD27, both markers that have been associated with memory formation in
other models. Additionally, the c-Rel-/- OVA-specific CD8+ T cells responded better to
secondary challenge as compared to the WT cells by expanding to a greater degree. This
second finding suggests that c-Rel is not required for proliferation of memory T cells, and
provides one potential mechanism whereby c-Rel-/- mice could generate better CD8+ T
cell memory based on their primary expansion in a low IL-12 environment (Figure 28).
Other cytokines such as IL-2 have also been shown to contribute to memory CD8+ T cell
development and so the role of additional cytokines or growth factors cannot be
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discounted (Kalia et al., 2010; Pipkin et al., 2010; Williams et al., 2006), but were not
examined in the course of this thesis work.
Another important direction for the field of immunity to infection is to gain better
understanding of the transcription factors that regulate developmental pathways of CD8+
T cells and their differentiation into effector and memory cells. For example, my work
with CPS-OVA parasites, in agreement with an expanding literature, suggests that IL-12
levels are a critical regulator of CD8+ T cell expansion as well as memory formation. IL12 has been shown by a number of others to regulate expression of the transcription
factors T-bet and Eomesodermin (Takemoto et al., 2006), a pathway which recent work
has demonstrated is likely dependent on the mTor kinase (Araki et al., 2009; Rao et al.,
2010). While c-Rel does not seem to play a CD8+ T cell-intrinsic role in the studies
presented here, its importance in regulatory T cells might be exploited therapeutically to
make existing vaccines, or responses of memory cells upon challenge, more effective.
Full understanding and more complete identification of the downstream targets of T cellspecific transcriptions factors, and the protective effector functions induced following
their activation, could make drug treatment or vaccines work more effectively. In
summary, the work presented in this thesis has examined some of the factors required for
generation of an optimal CD8+ T cell response, and formed the basis for on-going studies
related to CD8+ T cell memory. Further, these studies have demonstrated the importance
of the inflammatory environment and the contributions of T cell-extrinsic factors to the
generation of adaptive immune responses to T. gondii. Better understanding of these
factors will be important not only to further understanding of the biology of parasite
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infection, but will also inform future research into vaccines or treatments against
pathogens that affect human health and disease.
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